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SID1HARY 
Halogenation of tyrosine, uracil, cytosine, uridine and histidine 
has been attempted - using both the enzymatic catalysis and chemical 
oxidation labelling methods - \dth I-125 and Br-80m. Chemical and 
enzymatic halogenation gave high yields of iodinated tyrosine, uracil, 
cytosine, uridine, and histidine, and brominated tyrosine, uracil, and 
cytosine. 
Reverse phase high pressure liquid chromatography separation and 
gel filtration were both investigated for use in the isolation and 
analysis of the labelled products. HPLC was most successful and had 
the advantages that; 
1. The technique \oJas fast enough to use \o~i th short-lived radiohalogens, 
i.e. t1 20mins (such as I-128, ti = 25 mins). 
~ 2 
2. The products were pure and free from interfering impurities. 
It \-ras found that the use of chemical oxidation and enzymatic 
catalysis labelling coupled \dth reverse phase HPLC separation provided 
a very rapid method of obtaining high specific activity of radiohalogenated 
compounds in aqueous solution completely free from buffering agents and 
non-halogenated parent compounds. 
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1.1. General remarks: 
CHAPI'ER I 
INTRODUCTION 
When biomolecules are labelled with a suitable tracer, their 
paths through the body can be traced, the time they spend in various 
compounds and organs in which they are incorporated determined, and 
the paths via which they ultimately leave the organism followed. They 
can be used to diagnose many diseases and for radioimmunoassay. It 
is essential, therefore, that the labelled biomolecule behave as much 
like the native biomolecule as possible, especially during the biological 
processes under consideration. An ideal label from this standpoint 
would consist of substitution in the molecule of another isotope of an 
atom already present; such atoms are carbon, hydrogen, nitrogen, oxygen 
or sulfur. However, atoms foreign to the biomolecule may be attached 
to sites on the biomolecule such that its properties are vitally 
unaltered. Foreign labels often have nuclear properties which make them 
superior to isotopes of elements found in biomolecules, and-the procedures 
for attaching foreign labels are often faster and simpler than those 
incorporating radioisotopes of naturally occurring elements. 
Short-lived radioisotopes are advantageous for use in medical, 
chemical, and biological studies since they involve lo'lorer radiation 
doses and less hazards of radioactive contamination than do long-lived-
radioisotopes. Host radioisotopes are produced by nuclear reactors 
and cyclotrons, which are located only in large nuclear centers. Thus 
short-lived radioisotopes are not readily available for use at large 
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distances from where they are produced. 
Due to the relatively low cost and simplicity of operation of 
14-MeV neutron generators, they can easily be purchased even by small 
institutes. Thus, it is desirable to develop methods of producing and 
separating short-lived radioisotopes using a 14-MeV neutron generator. 
As a result, the irradiated material cannot be used without processing 
and the radioisotope produced has to be separated from the target. 
For (n, p) and (n,oL) reactions which produce radionuclides of elements 
different from that of the target element a chemical separation is 
possible. The separations for (n, 2n) and (n, ~) reactions can be achieved 
by elution techniques(fdr solid targets) or by simple extraction (for 
liquid targets). In elu~ion techniques, the sample is put on the column 
and eluted using an appropriate solution. Such processes are 
advantageous from the point of view of cost, since the 'target material 
can be used repeatedly. 
In the case of large halogenated molecules, such as the polypeptide, 
hormones, purification from halogenating reagents, buffering solution etc. 
can be achieved readily using gel filtration. However, for smaller 
molecules, such as halogenated amino acids, purification is more 
troublesome, usually requiring ion-exchange or adsorption chromatography 
which in turn introduces difficulties, such as those isolating the labelled 
compound from the eluting agents. 
1.2. Choice of a suitable radionuclide for labelling. 
Consideration of the following points is vital when a label and 
labelling methods _are being chosen for a particular protein and its use (1). 
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a) The chemical nature of the element used as a label must be 
such as that it "lill form a stable bond \·d th the biomolecule. A label 
which becomes free from the biofuolecule during a study may interfere 
seriously l'.rith the measurements being made. 
b) The label, as \·tell as the labelled biomolecule and its possible 
decomposition products, must be safe for a patient subjected to in vivo 
medical studies. Decomposition products should not sho\-r an affinity for 
a particular organ, as this may interfere with the study and also produce 
a high localized radiation dose. 
c) The radionuclide used as a label for in vivo studies should 
emit in high abundance a gamma ray from 20 to 510 KeV, to permit 
detection by collimated Nai/Tl scintillation crystals. If the energy 
is greater than 100 KeV, there is very little absorption of the energy 
radiation by tissue. Ideal gamma rays, therefore, have energies of 
100-510 KeV. An ideal radionuclide should have low yieids of low 
energy photons following electron capture or internal conversion, and 
particle emissions such as beta particles, Auger or conversion electrons. 
These radiations increase the radiation dose to the patient due to their 
ease of aosorption in tissue, but they do not contribute to the efficiency 
of detection. 
d) The radionuclide should have the shortest physical half-life 
that is close to the physiological half-life of the phenomenon under 
study. 
e) The method of labelling should not damage the biomolecule. 
Preferably, the only change in the structure of the protein should be 
the addition or substitution of the label itself. Biomolecules vary 
in their degree of sensitivity to variations in pH and the presence of 
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oxidizing and reducing agents, and in the question of retention of 
biological activity after the attachment of a label. This requires that 
a labelling method be', tailored specifically to a biomolecule. 
f) The method of labelling should bind the label in high yield, 
especially in cases in which the radionuclide is expensive (e.g., cyclotron-
produced). 
g)· The labelled biofuolecule should be produced at a high specific 
radioactivity. 
Although direct labelling has been accomplished with isotopes 
of elements normally found in biomolecules (carbon-14, tritium (2-5) 
sulphu~35(6)), these are often not the best nuclides for labelling. 
The labelling methods (usually biosynthetic) produce low specific 
activity products, the labels may exchange with other isotopes during 
use (especially tritium) and the beta particles emitted from these 
nuclides make in vivo studies impractical and external detection impossible. 
Short-lived, positron-emitting isotopes of carbon, nitrogen and oxygen 
cannot be used for biosynthetic labelling O\>.ring to the time required for 
the··~ labelling technique.· Chemical synthesis of biomolecules is also 
time-consaming and still limited to a few examples. 
There have been many attempts to bind metal ions to biomolecules. 
Many of the metals have attractive decay characteristics and therefore 
are much used in nuclear medicine, especially technetium-99m (?,8). 
Unfortunately, this and other metals (e.g. Indium-113m (9), Indium-11lm 
(10) Chromium-51(11) Copper-67 (12)} do not form a stable bond with 
most biomo1ecules, recause of their ionic nature. A few specific biomolecules, 
such as transferrin, have sites capable of forming a tight complex , 
4 
\dth a few specific metal ions (iron, indium and gallium). This limits 
the use of metallic labels. HO\'lever, Plutonium and americium (13, 14) 
have been found to bind strongly to biomolecules, especially bone 
sialoprotein, but their decay by alpha emission makes them highly 
dangerous for in vivo use. 
Non metals form the strongest bonds l'lith carbon in biomolecules, 
because they are able to bind covalently. Of the non-metal atoms, 
hO\'lever, only halogens can bind directly to carbon as single atoms; 
the other elements usually exist in higher valence states, requiring 
additional atoms (of hydrogen, for example) to form stable groups. 
Such groups containing radioactive atoms have been employed in order to 
label biomolecules ~dth the folloldng radionuclides: carbon-14 (15) 
sulphur-35 (6), phosphorous-32 (6). Unfortunately, these isotopes 
are not suitable for in vivo studies because of their beta emissions. 
Labelling ~dth a group of atoms has the potential of being a way 
of providing stable binding characteristics along \'lith good decay 
properties. In-111'' for example ~ras attached to biomolecules via a 
bifunctional chelating agent (16). Labelling with a charged multi-atom 
group has a greater risk of altering the biological properties of 
biomolecule than does labelling with a single atom, because of the larger 
size of the groups and their tendency to change the charge characteristics 
of the biomolecule. 
Halogens are the most attractive choice for protein labelling, 
due to their covalent nature and monovalence. Iodine has been used 
extensively for biomolecule labelling because of its reactivity and the 
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availability of more than one isotope with acceptable decay properties. 
Other halogens have not been well investigated for biomolecule labelling. 
Iodine isotopes: 
There are twenty-four radioactive isotopes of iodine, almost twice 
as many as any other physiological element, but only a few are suitable 
for biomolecule labelling for in vivo measurements., The isotopes 
and their decay modes are listed in table 1. 
Iodine-131 can be separated from fission products at very high 
specific activities. Its 364 KeV gamma ray is usually used in 
measurements, and it is emitted in 8o% of the decays. Beta particles 
(ranging from 250 to 810 KeV) are emitted in 10~~ of the decays. Since 
beta particles are easily stopped in tissue, the radiation dose from 
internal use of this radionuclide is high; 2.7 millirad per microcurie. 
The half-life 8.05 days is longer than necessary for many studies, 
increasing the radiation exposure. 
Iodine-125 decays 10~ by electron capture, producing low energy 
photons and energetic electrons due to conversion and Auger processes. 
The photons may penetrate overlaying soft tissues to an extent sufficient 
for some in vivo assays. The half-life is rather long (60 days) which . 
increases the amount of I-125 needed for administration to obtain a 
detectable counting rate and therefore increases the overall radiation 
exposure. This isotope delivers a radiation doee to tissue of 
approximately 3.3 millirad per microcurie. 
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Isotope 
117 
117 
118 
119 
120 
121 
122 
123 
124 
125 
126 
127 
128 
129 
130 
131 
132 
133 
134 
135 
136 
137 
138 
139 
TABLE 1 
Isotopes of Iodine 
7m 
14.5 m 
13.9 m 
19.5 m 
1.35 h 
2.12 h 
3.5 m 
13.3 h 
4.15 d 
60.2 d 
12.8 d 
stable 
24.99 9 
1.7x10 y 
12.3 h . 
8.05 d 
mode of 
decay 
.PlEC] 
fit-
,6+, EC 
,6+, EC 
EC,f3t-
EC,,f3+ 
;5.-[EC] 
EQ(noj3j 
EC,~ 
EC,(nopj 
EC, f3-,p-r 
2.26 h /J~ 
20.3 h /3~ 
52.0 m jY 
6.68 h 1r 
83 s p-
22.0 s IT 
5.9 s ft-
2. 7 s f!J' 
major radiations, energies (me V) 
X rays, 7.511, .:55, .6, 1.:15 
X rays, S' .5f1, • 78 
}3+, X rays,· 7, .511, .56, .62, 1.52 
+ . p, X ray_s, 7, .212, .27, .32, .511 
,a-~-, X rays, 7.511, .564, .• 69, .78 · 
X rays, -,r 0.159 (83%), e- 0.127 · 
.d ... , X rays, 7' .511, .605, .• 644, • 73, etc. 
X rays1 J' 0.035(7%), e- 0.004, 0.03 
,fJ; JJ+, X rays, Y, .386, .667 
)3~ X ray, -y. 441 , • 528, • 7 43,- • 969 -
.6; X rays, Y0.040 (9%); e- 0.005, 0.03 
fi'; 4 0. 419, 0. 538, • 669, . 7l::l-3, 1 • 15 
}3; X rays, Y .08, .284, .364 (82%), .637, 
.723 
jJ;)-.24 7 .52, .67(144%), .77(89%), etc. i 
fi; Y0.53 (90%) I 
..a·; Y (many; • 1_35 - 1 . 79) 
JY, Y (many; . 42 - 1 . 80) 
p-; ';/(many; o. 20 - 3. 2) 
n 
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Iodine-123 also decays 100'~ by electron capture, but the main 
gamma ray has an energy of 159KeV, thus decreasing self-absorption 
as compared to I-125. The short (13.3hr) half-life reduces the 
overall radiation exposure, although the half life is too short for 
studies to be carried out for several days. 
The other radioisotopes of iodine are impractical for in vivo 
use due to either their exceedingly short or long half-lives, large 
amount of beta radiation or a large abundance of high energy gamma 
radiation. 
Bromine Isotopes: 
The knovm isotopes of bromine are given in Table 2. The most 
suitable isotope for medical use is Br-77. It should provide a biomolecule 
label superior to radioisotopes of iodine for the follO\oJing reasons. 
a) Br-77 decays to Se-77 by electron capture (~9~~) and positron 
emission ( < 1%) (17). Its principal gamma emissions and their abundances 
are 242 KeV (30:~) , 300 KeV( 6%), 520KeV(24%) and 580 KeV( 7}6). The whole 
body radiation dose from Br-77 in the form of a plasma tracer would be 
about 0.4 millirads per microcurie. TP~s is approximately one tenth of 
the dose due to either I-125 or I-131, assuming the radioactivity remained 
as a true plasma tracer. 
b) Br-77 has a half-life of 56 hours which is closely matched to 
the time scale of many medical studies (18)~ 
c) Bromine bonds covalently to carbon \tri.th bond strengths higher 
than those of :1a:line-carbon bonds in similar compounds (19). Therefore, 
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Isotope 
74 
75 
76 
77 
77 m 
78 
79 
79m 
80 
80m 
81 
82 
82m 
83 
84 
85 
86 
87 
88 
89 
90 
TABLE 2 
Isotopes of Bromine 
36 m 
1. 7 h 
16.1 h 
57 h 
4.2 m 
6.5 m 
st. 
4.8 s 
17.6 r-n 
4.38 h 
st 
35.34 h 
6.05m 
2.41 h 
31.8 m 
3.00 m 
54 s 
55.6 s 
15.5 s 
4."5 s 
1 .6 s 
mode of 
decay 
IT· 
/3+,Ec 
p-
IT 
/r 
fi" 
fl~ 
;r 
)3-, n 
,tr;n 
;r,n 
n 
. 
major radi.ations & energies (meV) 
. p·(4. 7), )'0.511, 0.64 
jl(1. 70), )'0.285, 0.511 
pt(3.6), Y0.511, o.559, 0 .• 65, ·o. 75, o.85,etc 
;rco.34), Yo.2.4, o.3o, o.52, o.58, o.75, 
· · .0.82, etc. 
4 0. 1 08, e- 0. 094, 0. 1 06 · 
,8~(2.55), -y 0.511, 0.614 
4"0.21 
).J-(2.00),.6 ... (0.87), Y0.511, 0.618, 0.666 
40.037, e- 0.024, 0.036, 0.047 
;rco.;444),-to.ss4, o.619, o.698.; o.777;etc. 
Y 0. 046, 0. 777 , . 1 . 4 7 5, fJ-, e- · 
fl(0._93), }'0.530 " 
ft(4.68).; ·~ 0.81, 0.88, 1 .01, 1'.21, 1 .90, etc 
13-(2. 5) 
,8-(7 .1), ¥"1.29. •. 1.36, 1.56, etc. 
)3-(8.0),·(2.6), n0.3, )'1.44, 1.85, etc. 
't 0. 76 
n 0.5 
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brominated compo~nds should be more stable to,.,.ard hydrolysis than the 
iodinated analogues. 
d) Free bromide is not concentrated by the thyroid or any organ 
(20). Uptake by the thyroid is a serious problem with free iodide in 
vivo. 
Br-80m is another useful bromine isotope, which has a half-life 
of 4.38 hrs. and can be prepared very easily in the laboratory. It is 
useful only for studies that do not need a long time. 
Fluorine-18 as fluoride ion has found its principal use as a bone 
seeking agent since first reported (21 ,22). Recent \'IOrk lori. th fluorine-18 
has been extended to include the labelling of radiopharmaceuticals for 
organ: imag5.ng. F-18 has an excellent half-life ( 110min) for use in 
labelling and its positron decay allo\·15 easy detection. Interest in 
the preparation of 1~F -labelled compounds of biological importance 
i' 
is due to the fact that F for H substitution in some biologically 
active compounds leads to analogues having almost unchanged biological 
behavi~ur (23,24). 
Chlorine radioactive isotopes are not well investigated like iodine 
and bromine isotopes. They are Cl-34m ( t~ = 32.4m, emits "6 -rays 
2 
and [3+ particles), Cl-36 (t~ = 3.08 x 105y, emits /3 -particles only,) 
and Cl-38 (t~ = 37.12m, emits 0 -rays and/) -particles) (25). As we 
can see they are not suitable for in vivo studies either because of their 
short half-lives (Cl-34m, and Cl-38m) or for the high radiation dose wnich 
arises fromj1 -particles (Cl-34m, Cl-36, and Cl-38). Snyder et al (26) 
reviewed the preparation of glycerides labelled with Cl-38m). 
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The heaviest known halogen,astatine, in particular At-211 
(t, = 7.2 hrs), has also received renewed interest, as far as potential 
2 
radiobiological and therapeutic applications are concerned (2?,28). 
It was decided to use halogens to study the production of labelled 
compounds. I-125 was used for iodinations because of its useful half-
life and ease of detection. Br-80m was chosen for brominations because 
it could readily be produced in the laboratory. 
Table 3 indicat~~ the importance of the halogens in the field of 
chemistry, biology and medicine (29), and also (4) describes- some of the 
iodine and bromine-labelled pharmaceutical compounds and their applications. 
1.3. Methods of Iodination: 
Several methods have been used for labelling biomolecules With 
radioactive iodine. These are: 
A Chemical Oxidation 
B Electrolytic Labelling 
c Exchange Reaction 
D Conjugation Labelling 
E Excitation Labelling 
F Enzymatic Iodination 
A. Chemical Oxidation: 
A number of chemical methods for iodine labelling of various biomolecules 
have been developed. For example, the reaction \In th tyrosyl residues in . 
11 
Uses 
Adrenals 
Blood flow 
Blood volume 
Bone 
Bone marrow 
Brain and CNS 
Breast 
Cardiac 
Cisternography 
DNA labelling. 
Electrolyte studies 
Eye 
Gastric excretion 
Liver 
Lung 
.Hetabolism 
Pancreas 
Placenta 
Prostate 
Protein and hormone 
labelling 
Pulmonary function 
Renography 
Spleen 
Thyroid Studies 
Tumour induction 
Tumor scanning 
TABLE 3 
Elements used 
C, F, I 
At, Br,C,Cs, In,I,Fe,Kr,Pb,Mn,N,O,K,Rb,Sc,Sr,Xe 
As,C,Cr,Ga,In,I 
Ba,Be,C,Dy,F,Ga,Fe,Pb,Sr,Tm,Sn 
Dy,In,I,Fe 
As,At,Bi,Br,C,F,Ga,In,I,Kr,Mn,O,K,Sr,Xe 
At,Bi,F,Ga,Pb,Sr 
C,Cs,F,I,Kr,N,O,K,Rb,Tl,Xe 
At,Ga,In,I,Pb 
C,I 
Br,K 
Ga,I,Pb,Zn 
Cs,F,I,Fe 
F,Ga,In,I,Sr 
C,Ga,In,I,Kr,Hg,N,O,Sr 
As,Be,C,F,I,Fe,Pb,O,Rb,Sc 
C,F,I,N,Rb,Zn 
C,Dy,F,Ga,In,I,Kr 
F,Ga,I,Sr,Zn 
I 
C,Ga,In,I,Kr,N,O,Rb,Xe 
C,Ga,In,I,Fe,~b,V 
C,In,I,Fe,Kr,Rb 
At,F,Ga,I 
At 
As,C,F,Ga,In,I,Mn,Hg,N,O,Sc,Sr,Tm,V,Zn 
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Compound 
iodobleomycin 
3,5 diacetamido-2,4,6-
triiodobenzoic acid 
(Hypaque) 
5-iododeoxyuridine 
iodofibrinogen 
17-iodoheptadeanoic acid 
o,m,p-iodohippuric acid 
iodinated human serum albumin 
4-iodophenylalanine 
iodinated Rose Bengal 
iodinated indocyanine green 
iodocytosine 
brominated albumin 
brominated fibrinogen 
brominated thyroglobulin 
TABLE 4 
Labelling method 
!Cl 
isotope ex~hange 
!Cl 
Xe-KI03 
ICI,electrolysis,Xe-KI03 
I-for-Br-exchange 
isotope exchange, !-for Br 
exchange, Xe-Kl03 
Xe-exposure, !Cl" 
isotope exchange 
Xe-exposure 
TlC~3·isotope exchange 
enzymatic, chloroperoxidase 
enzymatic, chloroperoxidase 
enzymatic, chloroperoxidase 
Application 
brain imaging 
urography 
control of tumortherapy 
thrombus localisation 
heart muscle metabolism 
renography 
cardio-pulmonary dynamics 
pancreas imaging 
liver function test 
eye melanoma imaging 
DNA,RNA investigation 
clot localization 
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36,37,32 
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42 
43,44 
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Compound 
bromodeoxyuridine 
bromotyrosine 
.B -bromo 0(..-amino butric acid 
TABLE 4 continued 
Labelling method 
KBr03,c12 
KBro3,c12 
Application 
pancreas localization 
'----
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proteins is the basis of iodine labelling of proteins although iodine 
reactions with sulpl:lhydry 1 groups or with his:tidine may occur to some 
degree. The reactions with the tyrosyl residues are illustrated below. 
They involve ionic reaction between cationic iodine and an ionic 
phenolate ion (49) 
(1) 
(2) 
(3) 
The conditions of iodination may be optimized regarding pH and iodide 
ion concentration. The resulting labelled biomolecule with either one 
or two atoms of iodine per molecule of protein constitutes a fairly 
stable tracer. Radioiodine is available in the reduced form, i.e. as 
iodide I-. Since all iodination reactions require the oxidized form, 
the radioiodide must be treated \nth an oxidizing agent or converted 
to KI3 reagent (50,51). A number of oxidizing agents·, including nitrite, 
iodate, persulphate., and hydrogen peroxide'. have been used (52,53,54). 
In all these methods the maximum utilisation of radioiodine is only 
one-half the total radioiodine, as can be seen from reaction (1). 
These methods are thus not attractive from the viewpoint of high specific 
activity preparations with small quantities of radioiodine. 
Iodination with cationic iodine I+ was first introduced by 
McFarlane (55) as seen in the reaction below, in which all iodine is 
fully utilised enabling high-specific activity preparations to be 
achieved (56,57). 
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(4) 
+ HCl (5) 
Several modifications of the iodine monochloride method have been 
.. -·~ 
proposed for labelling proteins; human serum albumin, L-tyrosine and 
other biomolecules at milligram levels (58-64). \'/hen a high specific 
activity labelled biomolecule is desirable, this method is not the best. 
The presence of carrier iodine requires iodination of each biomolecule 
with several iodine atoms to obtain high specific activities. This can 
lead to loss of biological activity which can occur even at levels of 
one or t\'10 iodine atoms per molecule of a biomolecule (58). 
The chloramine-T method is more widely used as an alternative to 
this method of iodination. The chloramine-T reaction, first described 
by Hunter and Greem1ood (65,66), employs chloramine-T as a mild oxidizing 
agent for iodide for the preparation of labelled_human growth hormone 
(HGH). Chloramine-T is the sodium salt of N-monochloro-derivative of 
p ·-'-toluene sulphonarrd.de, \'lhich in aqueous solution slO\'Ily forms 
hypochlorous acid, producing mild oxidizing conditions 
+HOCl ( 6) 
S02 NHCl 
Essentially this reaction is similar to iodination with iodine monochloride 
formed as an intermediate, and thus quantitative incorporation of 
iodine into protein molecules is achieved. The reaction is strongly 
dependent upon pH and on the topographical environment of the tyrosine 
within the protein molecule (67,68). 
B. Electrolytic Labelling: 
The constant current electrolytic method reported by Rosa et al 
I 
I (69) is theoretic~lly very simple and should yield labelled biomolecules 
with least damage. Its use in miGrogram-level labelling of biomolecules 
has been limited (70-72), although the method itself merits more 
attention. The method is based on the.electrolysis of a solution of 
radioactive iodine in the presence of the bioinolecule to be labelled. 
The advantagesof the electrolytic iodine are 
a) there is no need of chemical oxidizing agents, 
b) the possibility exists of controlling the rate of liberation 
of iodine and, 
c) there is a possibility of using extremely dilute solutions of 
radioactive iodine, thus reducing the amount of iodide introduced 
into the molecule for a given specific activity. The product 
does not show modification of its original characteristics (72). 
C. Exchange Reaction: 
Some compounds (73,74,44) which contain iodine atoms can be rendered 
radioactive by a si~ple isotopic exchange reaction \~th radioiodide, 
thus triiodothyronine and thyroxine can be radiolabelled by exchange 
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------------------------------------------------
~nth radioactive iodine. (radioactive iodine is formed in the reaction 
vial itself). By mixing radioiodide with iodine the exchange reaction 
is shown below 
\ 
*I---- *I 2 
I . I COOH 
+ HoQ-o-Q-cH2-CH-NH2 
I I 
(7) 
---
o-"I I. COOH I +HO~ ~ O~CH -CH-N~- (B) 2 -- - 2 ''2 
•r I 
_ Thyroxine 
A~·number of experimental variables (such as temperature and pH) have 
been reported \<rhich optimise these exchange reactions, and radiochemical 
yields of 9~/o have been reported (73) for 131r- thyroxine within 10-15 
minutes. This method is not desirable for high-specific active biomolecule 
production, because not all the biomolecule will be radiolabelled. 
i 
\ 
D. Conjugation Labelling: 
A ne\or method for labelling biomolecules (as protein hormones) \olith 
radioactive iodine for use in RIA has been reported by Bolten and Hunter 
(75). This procedure involves the preparation of a .. 1251-labelled ester 
molecule by the chloramine-T method and purification of the same from 
all oxidising and reducing agents, and subsequently conjugating the 
ester to any free amino group of protein or polypeptide molecule as sho'm 
in the following scheme: 
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HO 
Chloramine-=r iod-
ination reaction ~H2 ~c-· c~ H -eH-e-o-~ 1 +Nar 
" "c-cH 0 6' 2 
3-{p-hydroxy phenyl)propionic 
acid N-hydroxy succinimide 
ester 
I 
C=O NH I 
NH2{C H2)4 - CH I + 
Conj~ation 
Iodinated ester 
C=O 
I NH 
1 
-amino group at 
lysine or N-terminus 
in protein to be 
labelled 
reaction 
HO 
.:t:I 
I 
CH C=O 
I 2 NH 
H~CH-C-N- (CH )-CH •. (~I la betted protein) 6 2 ~ C=O 
( 9) 
(1 0) 
K.JH This approach is not only convenient for peptides that lack tyrosine, 
as for example secretin (76), but also for those hormones which are 
constantly reported to be altered in their immunologic reactivity by 
iodination (77) of tyrosyl groups. In the case of HGH, the method has 
been reported to yield tracers giv~ higher assayi~g sensitivity than is 
achieved using the chloramine-T method (75). 
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E. Excitation Labelling 
Recently, direct decay induced labelling (excitation labelling) has 
been reported using reactive iodine species resulting from the desay 
at Xe-123 and Xe-125 (38,78,79). The radioactive decay of these 
isotopes are 123X(EC, ~~) 123r and 125xe(EC)125r respectively yielding 
charged iodine species which can presumably react as such with the 
substrate molecule leading to radioiodine labelled molecules. In general, 
however, decay-induced labelling of solid biomolecules gives only poor 
yields, mainly due to the fact that the solubility of Xe in organic solids 
is very low and the labelling process takes place essentially at the 
surface of the solid substrate (80). Two methods of this type have 
been developed so far. The first was reported by Lambrecht et al (61) 
and consists essentially of the carrier-free preparation of the classical 
iodination reagent iodine monochloride via the decay of 123xe· in chlorine 
123 ... I C12 123ICl 
-
(11 ) 
The second method was reported by El Garphy and Stocklin (81) which 
is based on the preparation of a reactive iodination reagent via the 
decay of 123xe on solid Kro
3 
KIO 12310-
3_. (12) 
Due to these developments, radiochemical y:i.e:lds in the range of 30-
9~fo are obtained (33) by excitation labelling. 
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F. Enzymatic Iodination: 
Enzymatic oxidation of iodine by lactoperoxidase instead of 
chloramine-T has been recommended for labelling of various oiomolecules 
in microgram quantities (82-84). Since the system does not contain any 
chemical oxidizing or reducing agents (only small amounts of hydrogen 
peroxide are needed as catalyst) 1 t.his offers a gentle means for 
iodination of biomolecules to high specific activity. This method further 
provides a means for accurately controlling the amount of iodine 
incorporated-into biomolecules. The method has been applied successfully 
for the iodine labelling of HGH, insulin, glucogen, · human leuteniziilg 
hormone (Iu~), human follicle stimulating hormone (FSH), and 1-tyrosine. 
Also other peroxides (such as chloroperoxidase) have been used (85-88) 
for the iodination of biomolecules. 
It has been possible by covalently coupling a lactoperoxidase 
preparation to cyanogen bromide-activated sepharose-4B, to develop a 
technique for the iodination of biomolecules which does not require the 
introduction of contaminating materials. Sepharose-bonded lactoperoxidase 
appears to be stable over long periods llhen stored at 4°C in phosphate 
buffered saline (PBS) containing 10-5M t.hiomersalate (as antibiotic). 
Iodination reactions may be carried out over a broad range of conditions 
of pH, temperature and iodine concentrations. An additional advantage 
of this newly developed procedure is that following the iodination 
procedure, the sepharose-bonded enzyme can readily be removed by low 
speed centrifugation. 
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1.4. Hethods of Bromination. 
Bromine has several advantages for labelling of biomolecules. 
Due to the stronger C-Br bond, compared with C-I bond, the extent of 
hydrolysis should be smaller than that of iodinated compounds, and the 
56 hr (Br-77) half-life is closely matched to the time scale of many 
medical studies. 
Several methods have been used for the labelling of biomolecules 
with radioactive bromine. These are 
A - Excitation Labelling 
B - Exchange Labelling 
C - Enzymatic Labelling 
A - Excitation Labelling: 
The direct decay induced Br-82 (or Br-80m) labelling by exposing 
the solid substrate molecules, such as deoxyuridine ,1 L-tyrosine, 
guanosine, deoxycytodine, phenylalanine and acetic acid to gaseous 
CF38~r (or CF380mBr) was recently studied (47, 89). The radiochemical 
yields of brominated products were ~elatively , small and ranged from 
~~ in the case of bromo-deoxyuridine to 11% for bromoacetic acid. The 
method was modi~d (47) by adding chlorine gas to the reaction mixture 
which improved the #eld. in several cases (up to 80}~ for bromo-guanosine 
and bromo-L-tyrosine). Similar improvements can be achieved by exposing. 
crystalline KBro3 for some time to CF3
82Br(or CF380~r) and dissolving 
subsequently the KB~o3 in an acidic solution of the substrate. 
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B - Exchange Labelling: 
Many cases are kno~m where labelling can be achieved by isotopic 
or by nonisotopic exchange reaction. The reaction can be either 
electrophilic via positive halogens or nucleophilic via halide, 
or even homolytic process via halogen atom. It can proceed in solution 
or a molten organic system. Labelling procedures based on heterogeneous 
exchange reaction in solid/gas or soliq/liquid systems were recently 
developed (90)~ This technique makes .exchange. labelling attractive 
when compared with labelling by exchange in solutions or suspensions. 
The degree Of exchange obtained using this technique can be large and 
extremely small a~ounts of biomolecules can be labelled and isolated 
r~pidly and with a high degree of purity. The technique has been used 
to prepare aliphatic compounds (90) labelled with Br-82. 
C - Enzymatic Labelling: 
The enzyme chloroperoxi~ase is the only enzyme used for the 
bromination of biomolecules. It can also utilize chloride and iodide 
as well as bromide ions, and catalyse the formation of a carbon-halogen 
bond in the presence of suitable acceptor molecules, such as p -~eto 
acids, cyclic p ~i~etones and substituted phenols. In the enzymatic 
bromination technique only a small amount of hydrogen peroxide is 
required as a catalyst, and this method offers a gentle procedure for 
the bromination of biomolecules. Welch et al (45) have labelled L-tyrosine 
and proteins with Br-77 using the enzyme chloroperoxidase. They obtained 
yields of 75% bromo~yrosine, 8~fo labelled albumin and thyroglobulin. 
Knight et al (1) have · also preparen 77Br-labelled fibrinogen using the 
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intermediate enzyme labelling ofacylating agent N-succinimdyl-3-3(4-
hydroxphenyl) propionate (SHPP) with carrier free Br-77. Labelled 
SHPP was then allowed to conjugate with fibrinogen. The labelled 
fibrinogen was found to be > 90% clottable. 
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1.5. Purification of Labelled Biomolecules: 
The clean up of labelled biomolecules from the reaction mixture 
is essential for the removal of unreacted radiohalide, the reactants, 
and the damaged halogenated biomolecules. Depending upon the differences 
in the labile properties of the biomolecule being halogenated and their 
susceptibility of degradation, various separation methods are used, 
and these are broadly classified under dialysis, gel filtration, 
adsorption chromatography, ion-exchange chromatography, and gel 
electrophoresis. Gel filtration using a molecular sieve material like 
Sephadex is a simple and efficient procedure in which the labelled 
material and reactants are applied to the column and the degraded 
biomolecules, the pure biomolecules, mineral salts and unreacted isotop~ 
are then eluted in that order. The choice of the s·ephadex is based on 
the molecular \veight of the pa:rticular biomolecule (e.g. proteins or 
amino acids) under investigation. Thepreconditioning of the column 
with a protein such as albumin seems not only to saturate nonspecific 
adsorption sites on Sephadex but also to readily absorb damaged biomolecules 
onto the column ( 91). Adsorption chromatography is carried out '1-ti th 
powdered cellulose or synthetic silicates such as QUSO G32. The 
undamaged halogenated biomolecule is retained on the absorbent and 
subsequently desorbed by elution with albumin or even with dilute 
hydrochloric acid. Chromatoelectrophoretic procedures on poly-
acrylamide gel or starch gel are highly selective for fractionation of 
labelled biomolecule in which the pure labelled biomolecule remains at 
the origin, while migration at degraded biomolecule and free unreacted 
isotope occurs. The ion-exchange chromatography columns containing 
Do\'rex resin, anion exchange resin, or DEAE (diethyl amino-ethyl) cellulose 
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have also been employed selectively in some separation methods. Either 
one or a combination of the above purification procedures is employed 
depending upon the degree of purification to be achieved in a particular 
labelling procedure. Gel filtration employing .Sephadex has been the most 
useful procedure for a number.of systems. 
Recent progress in high-performance liquid chromatography (HPLC) 
has revived the interest in non-polar stationary phases. In fact, at 
present, the most widely used chromatographic technique, which is often 
referred ·to as "reversed-phase" chromatography, employs silica gel with 
covalently bound hydrocarbonaceous function, such as.octadecyl moieties, 
as the stationary phase. Retention is attributed to hydrophobic interaction 
between the solutes and the hydrocarbonaceous functions. Consequently 
the species are eluted in the order of increasing hydrophobicity. 
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CHAPI'ER 2 
EXPERIMENTAL 
The procedures used for iodination of the small biomolecules 
with I-125 were chloramine-T and solid state lactoperoxidase enzyme 
labelling methods. The bromination procedures of the same biomolecules 
were the chloramine-T and chloroperoxidase enzyme labelling methods. 
Most of the reagents (listed below) were analytical grade. 
The organic compounds were tested on HPLC and there was only one 
peak on the chromatogram for each compound, i.e. they_were sufficiently 
pure. 
2.1. Materials 
Tyrosine, British Drug House~ Chemical Limited 
, 
Diiodotyrosine, Sigma London Chemical Company 
Uracil, Halewood Chemicals Limited 
Iodouracil, prepared in the laboratory. 
Bromouracil.Sigma London Chemicals Limited. 
Cytosine, British Drug Houses Chemical Limited 
Iodocytosine, prepared in the laboratory. 
Bromocytosine, Aldrich Chemical Company Inc. 
Uridine, 9~~' Aldrich Chemical Company Inc. 
Bromouridine, Koch-Light Laboratory Limited. 
Histidine, 98%, Aldrich Chemical Company Inc. 
H2o2 , British Drug Houses ~emical Limited 
Chloramine-T, British Drug Houses Limited 
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Nai, Fisons Scientific Apparatus Limited. 
KBr, Fisons Scientific Apparatus Limited. 
Lactoperoxidase, For Analytical Purposes, Suspension in Ammonium 
Sulphate Solution, 3.2 mol/1; Potassium phosphate, 0.1 mol/1; 
pH ea 7, Specific activity ~a 200U/mg; Boehringe Hannheim GmbH. 
I 
Chloroperoxidase, Crude, Suspension in 2.7M(NH4)2so4 solution, 
pH3, Activity ea 5,400,000 units per mg Protein. 
Na2s2o5 , Fisons Scientific Apparatus Limited. 
Sephadex G-10, Pharmacia Fine Chemicals. 
CN-Br-Sepharose 4B, Pharmacia Fine Chemicals. 
I-125 Carrier free, Radiochemical Center, Amersham. 
I-128, Prepared in the Laboratory, 
Br-80m, Prepared in the Laboratory. 
Phosphate Buffer Saline (PBS) pH 7.0, O.OlH. 
Phosphate Buffer pH 7.0, O.Oll~. 
Phosphate Buffer Saline pH 7.4, O.OlM. 
Phosphate Buffer pH 2.78, 0.02M. 
Bromobenzene, Fisons Scientific Apparatus Limited. 
Ethyl iodide, Fisons Scientific Apparatus Limited. 
Preparation of Solid-State Lactoperoxidase: 
Lactoperoxidase was coupled to CNBr~activated sepharose-4B 
according to cuatrecases method (92). The resulting covalent bond(93) 
appears to be quite stable. 
Sepharose(agarose) is the registered trade mark for spherical 
agarose gel partic~es produced by Pharmacia. Agarose is a linear 
poly-saccharide consisting of alternating residues of D-galactose and 
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3,6 anhydro-D-galactose units, i.e., 
o~o 
OH 
n 
The immobilization method is simple and reliable, and the attachment 
of the enzyme to the matrix is performed under mild conditions. The 
method involves the activation of the polysaccharide with crrnr 
(Cl- or I-) to·give reactive imido carbonate which subsequently reacts 
with the protein. The chemistry of the activation coupling steps is 
as follows. 
a. activation 
0 
11 
o-C-NH2 
OH 
non-reactive 
OH o-c~N carbamate ho CNBr 
-HBr 
OH OH 0 
'\C==NH 
0/ 
reactive imido 
carbamate 
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b. coupling. 
0 
11 
0-C-NH-E 
OH 
NH 
N-substituted carbamate 
11 
o~c-NH-E 
OH 
0-
\ 
C==N -E 
I 
N-substituted iso urea 
(m ajar species) 
N -substituted imido 
carbamate 
The chemistry of individual steps shown in these equations is 
based mainly on observations made with appropriate model compounds. 
The method was first described by Axen et_al (94) in 1967 for the 
attachment of ~-chymotrypsin to sephadex and sepharose. 
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Procedure: 
The dried CNBr-activated sepharose-4B was allov1ed to swell in 
phosphate buffer saline, PBS, (O•OlM NaP04-o.IM NaCl pH 7.4) for 
2hrs. The swollen beads were separated on a coarse sintered glass 
funnel, and washed with cold PBS (pH 7.4), with the application of 
gentle suction. The desired quantity of activated beads (4mls of the 
settled beads) was transferred to an Erlenmeyer flask containing 
lactoperoxidase (0.8mg) in 8mls of the cold buffer and agitated on 
a shaker overnight at 4°C. The noncoupled lactoperoxidase was 
determined by optical density measurement of the supernatant material, 
at 412 nM, after removal of the beads (85). Coupling efficiency was 
98%. Bead concentration of lactoperoxidase was determined from the 
coupled enzirne (total lactoperoxidase added,less noncoupled enzyme) 
and the measured bead volume after settling in graduated cylinder. 
Atter thorough washing \d th cold buffer, the lactoperoxidase -containing 
beads were suspended in 0.211 glycine -O.OlH NaPo4 (pH7.4)-for a minimum 
of 5 hrs in the cold. The beads were then \'lashed thoroughly and stored 
at 4°C in phosphate buffer saline solution (PBS) pH 7.0. containing 
10-5M thiomersalate. The concentration of lactoperoxidase per ml of 
swollen beads was chosen to be the optimum found for the iodination of 
biomolecule, i.e. about 0.2 mg/ml according to David's \'tork (97). 
Preparation of 5-iodouracil (96) 
Uracil (0.4g) was dissolved in water (2mls) containing sodium 
hydroxide (0.13g). Pulverized iodine (0.7g) was added slowly to this 
solution. After all the iodine had been added, the solution was warmed 
up on a steambath until the iodine dissolved. The resulting solution 
was allowed to cool, the ioduracil separated from the cold solution 
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by filtration on a coarse sintered glass funnel, and then recrystallised 
from hot \1ater. 
Preparation of 5-iodocytosine (96) 
Cytosine (0.2g) ,.,.as dissolved in1vater (2mls) containing potassium 
hydroxide (O.llg). Finely pulverized iodine (o.leg) was slowly added 
to this solution, with frequent shaking. The reaction was smooth and 
the iodocytosine began to separate immediately. After all the iodine 
h_ad been added, the .solution- was warmed on a steam bath for a few minutes 
to complete the reaction. After neutralizing the free alkali Yrlth 
acetic acid, the iodocytosine was filtered off and recrystallized 
from boiling water. 
Determination of the Activity of Chloroperoxidase 
The enzyme was obtained in a crude form suspension in 2•7M 
(NH4) 2so4 solution, pH 3. The activity of the enzyme was evaluated 
by measuring its absorbance at 280 and 4o3nm. The ratio 
R = z 
optical density at 403 
optical density at 280 
is an indication of purity (98); and was found to be 0.5. 
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2.2. Production of Radioactive Isotopes 
I-125 was obtained from the Radiochemical Centre, Amersham. 
I-128 and Br-80m were prepared in the laboratory. A Kaman Nuclear fast 
neutron generator type A-l003was used. It was fitted with rotating 
target type RTH2C (Fig. 1), capable of generating a neutron flux at 
8 -1 -1 10 n cm s • 
The generator is a positive ion linear accelerator producing 
fast neutrons by the D-T reaction; the fusion of deuterium with tritium. 
Deuterium ions are accelerated through a high potential gradient, and 
strike a tritium containing target, where the exoergic reaction occurs 
2 H 
1 Q = + 17.6 MeV (11) 
The neutron energy in the forward direction is·· stated to be 14.74 me V 
(99). 
The irradiation procedures were as follows: 
Three sample bottles (52mm x 13mm) containing approximately 16mls 
of bromobenzene or ethyl iodide were placed at the irradiation position 
of the generator and irradiated for 30 mins. 
The irradiation of bromobenzene produced Br-78 (t1 = 6.5min) 
2 
along with Br-80m. The irradiated bromobenzene, therefore, ... ras left 
for one hour (~ 10 half-lives) to allow the Br-78 to decay. The 
recoil bromine, as radioactive Br-80m, was then extracted by means 
of the appropriate buffer solution giving carrier free Br-80m solution.~ 
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DEMOUNTABLE TARGET DISC 
SERIES RTH2 - Max. Di~. 6 inch {l 5? mm) 
MODEL RTH. 2C 
SCALE: FULL SIZE 
......... · .. --.. -· 
.,. ....................... : 
~tA:~·wcg; 
: :::~·:··: :·:· ==~:·~~-;-;~. 
ANNULAR 
Fi!S. 1. An illustrat~~n -of' the :b.rr;et disc. 
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ACTIVE 
TARGET AREA 
TARGET 
ACTIVE AREA 
.1-Hn. I. D. = 80 
Max 0. D.-= 147. m 
The nuclear reactions were 
81 Born... Br(n, 2n) tlr 
t1 :::: 25 min. 
2 
Iodine127 reacts with thermal neutrons, therefore, a piece of polyethylene 
was placed betvreen the target and ethyl iodide to thermalize the fast 
neutrons and thus produce I-128. After that the recoil iodide 
was extracted with phosphate buffer saline (PBS) giving I-128 carrier 
free solution. 
The extraction was carried out as follows: 
The sample bottles were opened and the contents discharged into a 25ml 
separating funnel containing l-2mls of buffer solution (0.01M pH 7.0 
·PBS for iodide extraction, 0.01 M pH 7.0 and 0.02M pH 2.78 of phosphate 
buffers for bromide extraction). Then the mixture was shaken for two 
minutes, transferred into centrifuge tubes and centrifuged for another 
2 min. The aqueous layer (upper layer) vrhich contained the recoil 
halide ions, was pipetted to another small test tube. 
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2.3. Labelling procedures: 
All labelling was carried out at room temperature. 
A Enzymatic iodination (Lactoperoxidase): 
An appropriate quantity of LP-4B (.$epharose-bond enzyme) 
suspension was pipetted into a small test tube (5Qmm x 9mm) containing 
approximately lml of O.OlM PBS pH 7.0. The beads were centrifuged 
and washed twice with lml of buffer. A solution of tyrosine (saturated), 
ura·cil (0.04mg), cytosine (0.2mg), uridine (lmg), or histidine (0.5mg) 
in phosphate buffer saline, PBS~· (O.OlM, pH 7.0), usually lml, was 
pipetted into the tube after the final wash had been removed by 
aspiration. Sodium iodide solution (carrier) was added, followed by 
about 2 )JCi of Na 125r. (approximately 10 - 50 }J 1). The iodination 
reaction was initiated by the addition of H2o2 solution. The LP-4B 
was kept in suspension by manual agitation throughout the course of 
the experiment. After an appropriate time, the reaction was terminated 
by the addition of aqueous sodium metabisulphite. The LP-4B was 
separated by centrifugation and the aqueous phase (0.5ml) was loaded 
onto the high pressure liquid chromatography column, from v1hich the 
components were eluted using distilled water. 
B Iodination of tyrosine with I-128: 
After the determination of the optimum conditions for the iodination 
labelling using I-125 isotope, the extracted solution of I-128 (2mls) 
in O.OlM PBS pH 7.0. \<Tere saturated with tyrosine. This solution (lml) 
was pipetted into a small test tube (50mm x 9mm) and labelling procedure 
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was carried out as described in section A (except the addition of 
125 Na I of course). 
C - Chloramine-T iodination: 
A solution (0.5ml) of tyrosine (saturated) or Uracil (0.5mg), 
cytosine (0.5mg), uridine (0.5mg) or histidine (0.5mg) in phosphate buffer 
solution(0.01M, pH 7.0) was pipetted into small test tube (50mm x 9mm) 
containing abo~t 2 )JCiNa 125r (approximately 10 - 50 }J1). The iodination 
reaction was initiated by the addition of chloramine-T solution (0.75mg 
in 75 )J l of distilled \·rat er)~ After 5 mins, the reaction \·/as stopped by 
the addition of aqueous sodium metabisulphite. Then, the reaction mixture 
(0.5ml) was loaded onto a Sephadex G-10, column, from which the components 
were eluted using phosphate buffer solution (0.01H, pH 7 .0). 
D - Enzymatic Bromination (Chloroperoxidase): 
A solution (0.5ml) of tyrosine (Saturated) or uracil (0.4mg), 
cytosine (0.4mg), uridine (o.4mg) or histidine (o.4mg) in phosphate buffer 
solution (0.02M, pH 2.78) \·ras pipetted into a small test tube (50tn_m x 9mm) 
containing an extracted Br-80m solution (0.5ml of 0.02M, pH 2.78). 
Potassium bromide solution was added followed by chloroperoxidase enzyme. 
The bromination reaction \..ras initiated by the addition of H2o2 solution. · 
After an appropriate time, the reaction was stopped by adding an aqueous 
solution of N~s2o5 • The aqueous layer (0.5ml) was loaded onto the high 
pressure liquid chromatograph an~or onto a Sephadex G-10 column. The 
components \..rere ·eluted using distilled water, for HPLC column, or 
O.Olli phosphate buffer solution (pH 7.0), for the Sephadex G-10 column. 
37 
E - Chloramine-T Bromination: 
A solution (0.2ml) of tyrosine (saturated), uracil (0.2mg) 
cytosin~ (0.2mg), uridine (0.2mg), or histidine (0.2mg) in phosphate 
buffer solution (O.OIM, pH 7.0) was pipetted into a small test tube· 
(50mm x 9mm) containing an extracted Br-80m (0.2ml) in phosphate 
buffer solution (O.OJ.H, pH 7,0). The bromination reaction \'ll'as 
initiated by the addition of chloramine-T. After 5 mins, the reaction· 
was stopped by the addition of an aqueous solution of sodium metabisulphite. 
Then the reaction mixture \'las loaded. onto a S'ephadex G-10 column~ 
from which the components were eluted using phosphate buffer solution 
O.OOIM, pH 7.0). 
2.4. Analysis 
Two systems have been used to separate and ahalyse the labelled 
biomolecule from their reaction mixture 
I - A High Pressure Liquid Chromatography system 
I! - .~ Gel Filtration system. 
I - A High Pressure Liquid Chromatography system 
The system consisted of 
A - Altex model 300 high pressure liquid chromatograph was used 
(Fig-2.1, fig. 2.2., table 5). Its main components were 
a) Pumping system: 
i) Air supply: 
The pump used in this model was a constant pressure pneumatic 
amplifier which used air or nitrogen to drive a large hydraulic piston 
which, in turn, drives a smaller piston to deliver the mobile phase. 
The amplification ratio l·ras 23:1, for example, an applied gas pressure 
of lOO psi \oJould give 2,300 psi' of liquid pressure. 
ii) Air drive section: 
The air drive section consist of one or more air driven 
piston assemblies, a cycling control valve, pilot valves mounted in 
the upper and lower end caps, a flow tube to direct flow to the top 
side of the air piston and a pilot tube to connect the upper and lower 
pilot control valves. The valve operates without springs ordetents 
and is cycled by alternately pressurising and venting an unbalanced 
pressure operated spool. 
iii) Hydraulic liquid chamber: 
The hydraulic liquid chamber is 70mls in volume and is 
connected to the reservoir via a check valve. When 70mls of the liquid 
has been pumped out, the air pressure is automatically reversed and 
the pump refills. This refill stroke takes approximately one second. 
The manual reset button allows the pump to be refilled at any time, 
e.g. before sample injection. During the refill stroke, a positive 
liquid flow is maintained by a check valve between the pump and column. 
iv) Purge/Recycle Valve: 
The three-way recycle valve, or purge valve is located 
between the pump and reservoir and provides for rapid solvent mixing when 
a modification of the mobile phase is required. This valve is also 
used to rid the liquid chamber of air to ensure a full 65-?0mls stroke. 
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TABLE 5 
HPLC SPECIFICATIONS 
FLOH RATE CHANGE -
Continuously adjustable to lOOml/min 
FLOW RATE REPRODUCIBILITY -
+ 1% 
__ PUMP PRESSURE -
100 to 3000 psig (7 to 210 atm). 
RESERVOIR VOLUHE - · 
2 liters. 
l1ATERIAL OF CONSTRUCTION -
R R All wetted parts are 316 SS, Teflon , Kel-F or Tefzel • 
OVERALL SIZE -. 
21" wide, 2011 deep, 31 11 high. 
ELECTRICAL REQUIRDIENTS -
115 or 230 V, 50/60Hz. 
DErECTOR -
Model 153 Analytical UV Detector with the standard 
wavelength of 254 nanometers. 
AIR REQUIRU1ENTS -
150 psig air or nitrogen to operate the instrument at its 
maximum pressure of 3000 psi (210 atm). 
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b) UV detec;tor: 
The Altex Hodel 150 UV (254 nm)was specifically designed for 
high resolution analytical and preparative liquid chromatography~ 
Its specifications are given in Table 6. The UV detector features 
double-beam optics, that are temperature compensated to reduce noise 
and drift due to room temperature fluctuations. The standard flow cell 
has a one· centimetre path length ,.n_ th a cell volume of 8 J.ll for 
a maximum resolution and sensitivity. The inlet line has a type 316 
stainless steel heat exchanger connected directly to the column end 
fitting. The heat exchanger allows the solvent to come to thermal 
equilibrium before being measured. 
c) High pressure sample injection valve: 
The high pressure valve (Altex model 905) is a rotary m..ritching 
loop valve with a pressure rating of 3,000 psi. Fig 0) shows the 
flow pattern of the liquid through the valve. This valve has an external 
removable sample loop with a total injection volume of 500J.ll. 
d) High pressure liquid chromatography column: 
The high pressure liquid chromatography column was a 1 x 25cm 
stainless steel column packed with lO~m ODS-sepherisorb (reversed 
phase). It was manufactured by Phase-Separation Ltd, and was supplied 
by Anachem Ltd. 
B - Radiation detection units consisting of: 
a) A Radiation detector: (Fig. 4). 
A hollow PTFE helix \V'as used as a radiation detection cell. The 
helix was made from 4ocm long and 1.6mm inner diameter tube, giving a 
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Table 6 U. V. Detector Specifications 
Type of Optical System 
Light Source 
Wavelength Range 
Stray Light 
Half Bandwidth 
Flow Cell 
Solvent Contact Materials 
Linear Absorbance Range 
Double beam, interference filter 
Low pressure Hg lamp and selectable phosphor screens 
254nm standard, 
Less than 0.3% (254nm) -~ 
0.2nm at 254, 313, 365, 4o5, 436 and 546nm 
l.Onm at 578nm; and 
typically lOnm for other wavelengths 
lOmm path length, lOO 1 volume standard 
Other flow cells directly interchangeable 
Tefzel®, sapphire, TeflonR. 
Noise to 1.0 A.U.* 
volume of 0.8mi. It \-tas held in the 'l'rell of a Nai/Tl well type crystal 
scintillation detector (Panax Equipment Ltd) \orhich connected to a 
single channel analyser. The Nai/Tl crystal (type 5\·JH) was l~n.dia. 
x 2·in. high, with a well of dimensions l8.2mm x 40mm. The crystal 
\-tas fitted 'l'li th a photomul tiplier type 6097. Both the crystal and the 
photomul tiplier \-tere held in a lead castle type LC-3S, \ci th l.06in 
average well thickness. 
b) Single Channel: 
The SR5 scaler-ratemeter (Nuclear Enterprises Ltd) was used to 
measure the amount ofrotivity that passed through the detector. In 
its basic form, the SR5 comprises a high voltage generator (0-2KeV), 
a linear pulse analyser, a ratemeter and a scaler/timer. The analyser 
consists of an a.c. coupled amplifier, \cith gain variable over a total 
range of 150:1, and a pulse amplitude discriminator. Energy selection 
for differential measurements is facilitated by a channel \ddth switch, 
by means of which a window can be opened symmetrically about the channel 
centre. The analyser incorporates bipolar pulse shaping, double different-
iating and single integrating time constants of ljJs• 
C) Recording unit: 
A RE571 Servoacribe-2S dual cross-over pens linear chart recorder 
was used to record both uv absorption and ~-activity. Each channel 
had an input of 0.5mv to lOOv with zero calibration suppression. The 
first channel was connected to the uv detector (input= lOmv), the 
second channel to_the single channel analyser (SR5) (input= lOOmv). 
The chart recorder had a response time of 0.5 sec and a reversible 8 speed 
gear box to give 30mm per hr to 600mm per min. 
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Technique: 
Fig (5) illustrates the high pressure liquid chromatography system 
The mobile phase (distilled water or methanol-distilled water mixture) 
was delivered from the solvent reservoir to the column inlet by a high 
pressure pump. 0.5ml-size- ;Ba.mples \vere introduced into column inlet via 
a loop injector. Solutes emerging from the column outlet v1ere passed 
through the uv monitor flow cell. The eluent was then passed through 
the hollow PTFE helix previously described and the counting rate 
displayed on the chart recorder along with the output from the uV: monitor. 
The amount of the radioactivity was measured by determining the 
number of counts at the end of the peak minus the number of counts 
before the starting of the peak minus the background. This can be 
converted into )JC i (the efficiency of the detector was 7C!Jio). 
"' 
The Measurement of Retention Volumes: 
The HPLC power vras turned on, and the uv detector allO\-Ted to warm 
up ( t\-TO hours) before the injection of the first sample. The column 
was washed first with redistilled methanol (to clean up the column from 
the impurities) and then with distilled water. After that sample from 
each of the following mixtures, listed belot-r, were injected and distilled 
water was used as eluent. 
iodide, tyrosine, iodotyrosine 
iodide, uracil, iodouracil 
iodide, cytosine, iodocytosine 
iodide, uridine, iodouridine 
iodide, histidine 
bromide, uracil, bromouracil 
bromide, cytosine, bromocytosine 
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bromide, uridine, bromouridine 
The retention volume was calculated as the flow rate times the time. 
Table (7) shows the retention volumes of each component. The uv 
absorption following hplc separation of iodide (inactive), tyrosine 
(uracil or cytosine) and iodo-tyrosine (iodouracil or ·iodo-cytosine) 
are shown in figures 6,7,8 respectively. 
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Table 7 
Retention volumes obtained using distilled water eluant, 
-1 lOmls min and 25 x 1 ems ODS~Spherisorb, 10 , column. 
Compound (a) 
Tyrosine 
3-bromo-Tyrosine 
3-iodo-Tyrosine 
Uracil 
5-bromo uracil 
5-iodouracil 
Uridine 
5-bromo uridine 
5-iodo uridine 
Cytosine 
5-bromo cytosine 
5-iodo cytosine 
Histidine (b) 
5-iodo histidine 
(a) Samples ,.., 50ug in 0.5ml water 
Retention volume/ml 
45 
82 
220 
25 
44 
60 
26 
84 
35 
30 
82 
80 
35 
55 
(b) Obtained by fraction collection and u.v. absorption measurements 
at 200-210 nm. 
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.. 
Calibration of the single channel analyser: 
. 
The single channel analyser (with Na.I/Tl l·rell-type crystal 
scintillation detector) had been calibrated for I-125 as follows, the · 
instrument controls lvere set as below 
E.H.T. dial 
channel% Slvitch 
Energy range mdtch 
Preset count suitch 
Preset time stdtch 
Display (ratemeter) suitch 
Display (scalar) swltch 
minimum· 
integration 
1 
off 
30 sec 
cps 
count 
Then the instrument was Slvitched on and was allow·ed to warm up {one 
· hour). 
Radioactive I-125 {in a sample bottle) was placed in the well, 
and gradually the EIIT was increased until the scaler began to count. 
A series of counts at suitable voltage intervallvere taken {table 8) 
until the counting rate began to increase rapidly. The count rate for 
the background was determined for the same voltage setting, in the same 
way {the optimum voltage for I-125 was found to be 1200 volts), and 
the variation of source counts less background, and background counts 
against EHT plotted on semilog graph paper (Fig. 9). 
Since the gamma energy of Br-80m isotope is about the same as 
I-125, this voltage was considered to be the optimum for Br-80m as well. 
The efficiency of the detector was calculated by comparing the 
scale reading of a small radioactive I-125 solution (about 0.1 U ci}, 
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at that detector vri. th the scale reading of another detector '.-Ihose 
efficiency Has kno':m (60%). The efficiency \·ras found to be 7Z~. 
Table 8. Variation of' the counts rate '"ith EHT 
Volt I-125/C/S B~G •. c/s c/s 
Boo 3 2 1 
870 4 4 0 
880 4 4 0 
920 .6 5 1 
960 26 5 21 
1000 83 6 77 
104o 1704 6 1700 
1080 2916 6 2910 
1120 4478 6 4470 
1160 4925 6 4920. 
1200 4968 6 4960 
124o 4961 6 4960 
1280 4981 6 4975. 
1320 4953. 6 4950 
. 
1360 4973 7 4970 
14oO 495lJ. 7 4950 
1440 lt961 9 4960 
1480 1~949 11 494o 
-1520 4937 18 4980 
1560 5095 38 5090 
1600 5479 . 108 5470 
16'+0 6130 230 6120 
6 
10 I 
1000 1400 
EHT 
,. 
0 source 
e Background 
FLg. 9. Variation of the counts rate with EHT • 
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II Gel Filtration System 
Instruments and Apparatus 
A - Gel filtration column: 
Two glass colmnns (Bio-Rad) were used, and each column was packed 
with swollen Sephadex G-10 beads. The dimensions of the column '"ere 
4ocm x ?mm x 27cm x ?mm for the iodine-iodinated and bromine-brominated 
biomolecules reaction mixture respectively~ 
The columns were made of borosilicate glass with polypropylene end 
pieces. The lower ends were' fitted ~dth strong nylon matts to hold the 
beads. 
B - Radiation detection units: 
See HP.LC system, section B. 
C - Pump. 
A peristaltic pump type Delta B (1;/atson-Harlot-1 Ltd) was used. 
Its main features were a drive system; a pumping module, and an end 
plate fig ( 10); The pump was fitted with t~10 nipple connectors. A 
silicon rubber U-shaped tube was wrapped around the rotor, and its ends 
were pressed onto the nipple right to the shoulder. The other ends of 
the nipple were connected to the rest of the circuit, by flexible PVC 
tubing. The pump had a fixed speed of 4 r.p.m., and the outlet from the 
pump was between 0.4 - 0.6ml per min, depending on the compactibility 
of the beads. 
D - Recording unit. 
Only one channel, of the same chart recorder that was mentioned 
in the description of the HPLC system - section c, was used and was 
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connected to the single channel analyser. No u.v. detector was used 
in this case because no sui table detector \oJas available. 
Technique: 
Figure (11) illustrates the gel filtration system. The dry gel, 
Sephadex G-10 was allowed to swell in a large quantity of buffer 
solution for 24 hrs, then the supernate was removed by decantation. 
The top of the column \oJas connected to the funnel. The m-rollen beads 
were transferred carefully through the funnel into the column. After 
the sedimentation of the gel, the column \oJas \·lashed several times with 
the buffer solution (0.01 phosphate buffer pH 7.0). A sample of the 
reaction mixture (about 0.5ml) was pipetted into the top of the column. 
Using the peristaltic pump, solutes emerging from the column outlet 
were passed through the hollow PTFE helix detection system, previously 
described, and the counting rate recorded on the chart recorder as 
before. 
Heasuring the Retention Volume: 
\-/hen the setting of the gel filtration system t-ras completed, radio-
active I-125 or .Br-80m was introduced onto the top of the column. 
Using 0.0111 phosphate buffer solution the radioactive material \'las 
• 
eluted and its retention volume measured. Then a biomolecule substance 
(like uracil) \'las introduced and its retention volume \otas obtained by 
fraction collection and uv absorption measurements at 260nm. A sample 
of reaction mixture (which contained the halide biomolecule and halogenated 
biomolecule) was introduced and the retention volume for the halogenated 
biomolecule was then measured (the reaction mixture which was first 
checked by HPLC). The retention volumes are listed in Table ( 9 ). 
60 
Table (9) 
Column, 4ocm x 7mm 
substance 
iodide 
·iodo-compound 
Column, 27cm x 7mm 
bromide 
bromocompound 
biomolecule 
retention volume 
llmls 
22mls 
20mls 
llmls 
12mls 
.. ~.· 
· ... ; 
.'• 
-~~ 
J. 
,.. Ca lu::1 il 
... ;; 
;::: 
:~-
Wast 
Puistaltic 
p:.::-:l p 
fl cw cell i·~ 
scintilla ti o~ 
·count e, 
Schematic of · Gl- L FllJRATION fitted vvith 
: . 
a continuous flov; radiooctiyqy detector· 
Fig. (11) 
CHAPTER 3 
RESULTS 
The radiochemical yield (Y) was calculated by means of the 
following expression, 
y = 
p 
p +X 
where P is the integrated count under the peak corresponding to the 
radiochemical product in the radiochromatographic pattern. X is 
the integrated count under the peak corresponding to the halide in 
the radiochromatographic pattern, 
All the halogenation (iodination· and bromination) reactions \-.rere 
,.- • I , 
done at room temperature. 
I - Iodine labelling: 
The influence of H2o2 concentration, I- carrier concentration, 
lactoperoxidase concentration and time on the iodination of tyrosine, 
uracil, cytosine, uridine, and histidine are illustrated in Tables 
10, 11, 12, 13 and 14 respectively. 
The radiochemical yields of the chloramine-T iodination labelling 
are given' in Table 15. 
II. - Bromine Labelling: 
The influence of H2o2 concentration, Br- carrier concentration, 
chloroperoxidase concentration and time on the bromination labelling 
of tyrosine, uracil, and cytosine are given in Tables,16,17,18 
respectively. 
The affect of Chloramine-T concentration on the bromination 
labelling is illustrated in Table 19. 
The variation of each parameter of the reactions mixture on 
the radiochemical are shown in Fig.12 to Fig.1 9. 
TABLE 10 
Yield of radio-iodotyrosine as a function of l~ctoperoxidase 
concentration H2o2 concentration, I- carrier concentration, . 
and time. 
H202 I - Time Lactoperoxidase Radiochemical 
,lg 10-5mole -6 min. yield % ! 3 10 mole 
4.0 o.o 20 15 o.o 
4.0 0.25 20 15 67. 
4.0 0.5 20 15 86 
4.0 1.0 20 15 87 
4.0 2.0 20 15 68 
4.0 1.0 0 15 17 
4.0 1.0 10 15 87 
4.0 1.0 20 15 89 
4.0 1.0 30 15 89 
4.0 1.0 4o 15 92 
4.0 1.;0 60 15 89 
4.0 1.0 70 15 87 
4.0 1.0 100 15 79 
2.0 1.0 20 2 59 
2.0 1.0 20 5 70 
2.0 1.0 20 10 73 
2.0 1.0 20 15 85 
2.0 1.0 20 20 90 
2.0 1.0 20 25 88 
2.0 1.0 20 30 86 
o.o 1.0 20 30 00 
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TABLE 11 
Yield of radio-iodo uracil as a function of lactoperoxidase concentration, 
H2o2 concentration, I- carrier concentration, and time 
Lactoperoxidase H202 Time Radiochemical 
lo-5mole -6 min. yield % :!: 3 yg 10 mole 
4.0 o.o 2.0 20 o.o 
~-0 0.5 2.0 20 33 
4.0 0.75 2.0 20 65 
4.0 1.0 2.0 20 80 
4.0 1-25. 2.0 20 83 
4.0 1-5 2.0 20 80 
4.0 2.0 2.0 20 77 
4.0 1-25 0 20 26 
4.0 1-25 1.0 20 69 
4.0 1-25 2.0 20 83 
4.0 1.25 2.5 20 80 
4.0 1-25 3.0 20 80 
4.0 1-25 4.0 20 76 
4.0 1-25 2.0 5 66 
4.0 1-25 2.0 10 83 
4.0 1-25 2.0 20 83 
4.0 1-25 2.0 30 84 
o.o 1.25 2.0 20 00 
2.0 1.25 2.0 20 51 
4.0 1-25 2.0 20 82 
6.0 1-25 2.0 20 77 
8.0 1-25 2.0 20 77 
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TABLE 12 
Yield of radio-iodocytosine as a function of lactoperoxidase concentration, 
H2o2 concentration, I-carrier concentration, and time 
-Lactoperoxidase H202 I Time Radiochemical 
)Jg l0-5mole -6 10 mole min. yield :!: 3 
4.0 o.o 4.0 20 00 
4.0 2.0 4.0 20 33 
4.0 3.0 4.0 20 57 
4.0 4.0 4.0 20 62 
4.0 5.0 4.0 20 70 
4.0 6.0 4.0 20 66 
4.0 7.0 4.0 20 63 
4.0 3-0 2.0 20 42 
4.0 3.0 5.0 20 
. 56 
4.0 3-0 6.0 20 58 
4.0 3-0 8.0 20 48 
4.0 5.0 4.0 10 45 
4.0 5~0 4.0 20 70 
4.0 5.0 4.0 30 69 
o.o 5.0 4.0 20 00 
0.5 5.0 4.0 20 65 
1.0· 5.0 4.0 20 77 
2.0 5.0 4.0 20 77 
4.0 5.0 4.0 20 73 
6.0 5.0 4.0 20 72 
TABLE 13 
Yield of the radio-iodnuridine as a function of lactoperoxidase 
concentration, H2o2 concentration, I 
- carrier concentration, and time. 
Lactoperoxidase H202 I - Tiine Raaiochemical · )Jg lo-5mole -6 yield% :!: 3 10· mole min~ 
2.0 o.o 12. 30 00 
2.0 1.5 12 30 84 
2.0 3.0 12 30 92 
2.0 6.0 12 30 90 
2.0 7-5 12 ) 30 89 
2.0 9.0 12 30 87 
.. 2.0 7-5 o.o 30 18 
2.0 7-5 3.0 30 77 
2.0 7-5 6.0 30 84 
2.0 7-5 7-5 30 78 
2.0 7-5 9.0 30 87 
2.0 7-5 12.0 30 89 
2.0 7·5 15~0- 30 91 
2.0 7-5 18.0 30 88 
2.0 7-5 7-5 10 66 
2.0 7-5 7-5 15 65 
2.0 7-5 7-5 20 73 
2.0 7-5 7-5 30 78 
2.0 7-5 7-5 4o 80 
0.0 7-5 7.5 30 00 
0.5 7.5 7-5 30 72 
1.0 7·5 7·5 30 79 
2.0 7·5 7-5 30 78 
4.0 7·5 7.5 30 79 
6.0 7·5 7-5 30 79 
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TABLE 14 
Yield of the radio-iodo~istidine as a function.of lactoperoxidase 
concentrations H2o2 concentration, 
- carrier concentration, and time. I 
Lactoperoxidase H202 I - Time Radiochemical 
10-5mole -6 min. yield% :t 3 g 10 mole 
2.0 o.o 4.0 20 00 
2.0 0.5 4.0. 20 7 
2.0 1.0 4.0 20 64 
2.0 2.0 4.0 20 91 
2.0 3.0 4.0 2.0 90 
2.0 4.o· 4.0 20 90 
2.0 5.0 4.0 20 90 
2.0 7-5 4.0 20 90 
2.0 9.0 4.0 20 89 
2.0 12.0 4.0 20 88 
2.0 3.0 o.o 20 73 
2.0 3-0 2.0 20 88 
2.0 3.0 4.0 20 90 
2.0 3-0 6.0 20 91 
2.0 3.0 8.0 20 92 
2.0 3-0 12.0 20 86 
2.0 3.0 15.0 20 ?0 
2.0 3.0 4.0 5 88 
2.0 3.0 4.0 10 89 
2.0 3.0 4.0 20 90 
2.0 3-0 4.0 30 90 
o.o 3.0 4.0 20 00 
0.5 3.0 4.0 20 90 
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Lactoperoxidase 
g 
1.0 
2.0 
3.0 
4.0 
6.0 
TABLE 14 cont'd 
3 .. 0 
3.0 
3-0 
3-0 
3.0 
I-
-6 10 mole 
4.0 
4.0 
4.0 
4 .. 0 
4.0 
TABLE 15 
Time 
min. 
20 
20 
20 
20 
20 
Radiochemical 
yield% :!: 3 
90 
90 
90 
89 
89 
The radiochemical yields of the chlora~ine-T iodination labelling 
method 
Compound Chloramine-T 
mg 
Tyrosine 0.75 
Uracil 0.75 
Cytosine 0.75 
Uridine 0.75 
Histidine 0.75 
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Time 
min 
5 
5 
5 
5 
5 
Radiochemical 
yield % :!: 3 
86 
95 
75 
86 
.I 
TABLE 16 
Yield of radio-bromotyrosine as a function of chloroperoxidase concentration, 
H2o2 concentration, Br- concentration, and time. 
-Chloroperoxidase Time Radiochemical H202 Br 
g 10-3mole lo-11mole min. yield :!: 3 
2.2 6.0 o.o 15 61 
2.2 6.0 1.0 15 74 
2.2 6.0 2.0 15 80 
2.2 6.0 3-0 15 81 
2.2 6.0 4.0 15 80 
2.2 1.0 2.0 15 80 
2.2 2.0 2.0 15 80 
2.2 4.0 2.0 15 81 
2.2 6.0 2.0 
.15 80 
0.6 2.0 2.0 15 80 
0.0 2.0 2.0 15 00 
1.1 2.0 2.0 15 83 
1.7 2.0 2.0 15 75 
2.2 2.0 2.0 15 80 
3-3 2.0 2.0 15 75 
1.1 2.0 2.0 5 81 
1.1 2.0 2.0 15 82 
1.1 2.0 2.0 30 77 
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TABLE 17 
Yield of radio-bromouracil as a function of chloroperoxidase concentration, 
H2o2 concentration, Br- carrier concentration , and time. 
H202 - Time Radiochemical Chloroperoxidase Br 
)Jg 10-3mole -4 10 mole min. yield % :!: 3 
2.2 2.0 o.o 15 81 
2.2 2.0 0.5 15 83 
2.2 2.0 1.0 15 84 
2.2 2.0 2.0 15 87 
2.2 2.0 3.0 15 88 
2.2 2.0 4.0 15 89 
2.2 0.5 2.0 15 86 
2.2 1.0 2.0 15 . 89 
2.2 2.0 2.0 15 87. 
2.2 3.0 2.0 15 89 
2.2 4.0 2.0 15 85 
o.o 1.0 2.0 15 00 
0.6 1.0 2.0 15 90 
·1.1 1.0 2.0 15 89 
2.2 1.0 2.0 15 89 
3-3 1.0 2.0 15 87 
1.1 1.0 2.0 5 88 
1.1 1.0 2.0 15 89 
1.1 1.0 2.0 30 89 
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TABLE 18 
Yield of radio-bromo cytosine as a function of qhloroperoxidase concentration, 
H2o2 concentration, Br 
- carrier concentration, and time. 
Chloroperoxidase H2<?2 B - Time Radiochemical 
Jlg 10-3mole -4 10 mole min. yield 9~ ± 3 
2.2 18.0 o.o 15 48 
2.2 18.0 0.5 15 63 
2,2 18.0 1.0 15 68 
2.2 18.0 1-5 15 68 
2.2 18.0 2.5 15 65 
2.2 6.0 1.0 15 60 
2.2 18.0 1.0 15 68 
2.2 24.0 1.0 15 56 
2.2 30.0 1.0 15 63 
o.o 18.0 1.0 15 00 
0.6 18.0 1.0 15 54 
1.1 18.0 1.0 15 65 
2.2 18.0 1.0 15 68 
3-3 18.0 1.0 15 65 
2.2 18.0 1.0 5 59 
2.2 18.0 1.0 15 68 
2.2 18.0 1.0 30 65 
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TABLE 19 
The radiochemical yields of bromotyrosine, bromouracil, and 
bromocytosine as a function of Chloramine-T concentration. 
Compound 
Tyrosine 
Uracil 
Cyi:osine 
Chloramine-T 
mg 
o.oo 
0.45 
0.75 
1.0 
1.25 
o.oo 
0.30 
0.45 
o.6o 
o-.75 
_o.oo 
0.30 
0.45 
o.6o 
0.75 
Time 
min. 
5 
5"' 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
Radiochemical 
yield % :!: 3 
00 
16 
43 
65 
60 
00 
60 
71 
23 
00 
34 
72 
76 
64 
TABLE 20 
Optimum reaction conditions for labelling the following biomolecules with I-125 
Biomolecules H202 
(-) I (mole) Time(min) lactoperoxidase (jJg) . + %yield (-:- 3%) 
Tyrosine 1 X 10-5 2 X 1.0-5 20 2 90 
-..J 
\Jl 
Uracil 1.25 X 10-5 2 X 10-6 20 •4 83 
Cytosine 5 X 10-5 4 X 10-6 20 1 77 
Uridine 7•5 X 10-5 7.5 X 10-5 30 1 92 
Histidine 3.x 10-5 4 X 10-6 20 0.5 90 
TABLE 21 
Optimtim reaction conditions for labelling of the follo~dng biomolecules with Br- 80m 
Biomolecule Br-(mole) Chloroperoxidase()J g) Time(min) 
Tyrosine 15 
Cytosine 2.2 15 68 
Uracil 5 88 
TABLE 22 
Optimum X.-e.action conditions for labelling of the following 
biomolecules with Br-80m 
Biomolecule Chloramine-T(mg) %Yield (:!: 3%) 
Tyrosine 1.0 
Uracil 0.45 88 
Cytosine 0.6 76 
77 
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CHAPrER 4 
DISCUSSION 
Small radio-halogenated biomolecules play an important role in 
nuclear medicine. In this work, some of these molecules were prepared; 
namely iodo-and bromo-tyrosine, iodo-and bromo-uracil, iodo-and bromo-
cytosine, iodo-uridine and iodo-histidine. Maximum yields were 
obtained by varying the conditions under which the reaction takes 
place. Since radioisotopes of short half-life, such as iodine-128, 
\vere studied, special care \vas taken to ensure that the labelling and 
• separation techniques were rap~d. Also it was important to exclude any 
harmful material, e.g. strong oxidizing agent, that might alter or 
destroy the biomolecule. 
The enzymes and chloramine-T produced electrophilic halogenating 
species which should demonstrate the same characteristics as any 
electrophilic agent in substituting aromatic compounds. Thus the rates 
of substitution of the aromatic nucleus by the electrophilic agent 
should be dependent on the electron density of the substitution site. 
The halogenating species generated by enzymes and chloramine-T does 
behave like an electrophilic agent in the iodination of tyrosine, uracil, 
cytosine, uridine, and histidine, and in the bromination of tyrosine, 
uracil, and cytosine. 
OH 
X 
~ NH 
C H2-C H2_CO OH (12) 
3 -halotyr os in 
. 88 
H (10 YNH 
0 
H 
x-(r-o + w YNH 
0 
5-halouracit 
_;,.. (Jo + H+ 
X~NH 
NH2 
5 -halocytosine 
HO.--fH20H Ho,---\H20H 
HO~ HO~ 
(lo + I' __ (NJo + H+ 
~H ·I~H 
0 0 
5- iodouridine 
where X i~ either I+ or Br+ 
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(13) 
(14) 
( 15} 
Enzymatic Halogenation 
Several mechanisms may be entertained as possibilities for the 
enzymatic halogenation reaction. Since an overall oxidation is required 
for the formation of a carbon-halogen bond starting from a halogen anion 
and the acceptor molecule, the role of hydrogen peroxide as an oxidant 
in the reaction is clear. Less clear, ho'"rever, is whether hydrogen 
peroxide oxidizes the halogen anion, the acceptor molecule, or both. 
Morris (lOO) has proposed the follo\dng mechanism for the halogenation 
reaction. 
E+2 + - (17) -E + H2o2 20H 
E+2 + x- c- +2 -E-x (lS) 
+2 -E--x 
-
E + (19) ~x 
E-x + + A E + A-x (20) 
In this proposed scheme, E represents lactoperoxidase or chloroperoxidase 1 
x is the halide under consideration, and A is the particular halogen 
acceptor used, 
Equations (17·) and (1? ) represent first the addition of hydrogen 
peroxide and then halogen anion to the enzyme. Equations Cl9 ) and ( 20) 
illustrate the formation of an enzyme-bond halogenium ion and the 
subsequent halogenation of an acceptor by· the halogenium ion. 
Lactoperoxidase was used in the solid state, i.e. immobilized on 
CI~Br-activated sepharose-4B. On the other hand, chloroperoxidase was 
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in the mobile form, because there \vas no available procedure to immobilize 
it on a suitable support (the advantages of immqbilized 
immobilized enzyme were discussed in the introduction). 
a. Lactoperoxidase iodination labelling. 
or non-
A very small &~ount of hydrogen peroxide was used as a catalyst 
and its influence on the iodination of tyrosine, uracil, cytosine, 
uridine, and histidine is shown in Fig. (12). Uracil, uridine and 
histidine exhibited yield curves \vhich levelled off at a maximum 
concentration of H2o2 , while radiochemical yields of tyrosine and 
cytosine dropped off at concentrations above a peak value. The 
reason for this difference is uncertain. 
The radiochemical yields were strongly dependent on the presence 
of I- carrier as can be seen for reactions of tyrosine, uracil, cytosine, 
and uridine v1ith I-125, (Fig. 13a and Fig. 13b) \•Thile the addition of 
I-:- carrier had little effect on the results \vi th histidine. Radiochemical 
yields of the iodo-biomolecules.,generally. dropped off as the 
concentration of I- carrier increased above the optimum concentration. 
This is due to the fact that I- carrier in this case, would decrease 
the probability of reaction of I-125 \'li th the biomolecule. Points shovm 
at zero I- concentration were obtained using carrier-free radio-iodine. 
The radiochemical yield in all cases, increased with time up to 
a ma-ximum after \vhich it levelled off (Fig. 14) ... This maximum was 
reached after 5 minutes in the case of iodohistidine and after 15 
minutes for the rest of the reactions. 
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The relation between the concentration of lactoperoxidase and 
radiochemical yields is shown in Fig. (15). The yields of radioiodo-
uridine and histidine reached a plateau, while those of radioiodo-uracil 
and cytosine increased to a maximum then dropped. This might be due 
to the self iodination of the enzyme, because the concentration of uracil 
and cytosine in the reaction mixture were lower than the concentration 
of uridine and histidine. 
One or two points on the tyrosine curves were repeated using 
I-128 or much higher activities of r~125. No significant deviation from 
the results shown in the figures were observed. 
~able (20) summarises the optimum condition observed for the 
enzymatic iodination labelling of the biomolecules mentioned in this 
work, together with their radiochemical yields. 
b. Chloroperoxidase bromination labelling. 
Tyrosine, uracil, and cytosine reacted successfully \dth the 
radioactive Br-80m to form the radio-bromocompound. On the other 
hand, the labelling of uridine and histidine with Br-80m was unsuccessful. 
In the case of histidine, it has been reported (101) that reaction 
between histidine and chloroperoxidase enzyme gives ammonia and probably 
a negative imidazole ring or a degradation product. The change in the 
histidine concentration was difficult to measure because the HPLC 
detector wavelength was 254nm (histidine absorbs at 200-210nm). 
The presence of Br- carrier had little effect on the bromination 
labelling (Fig. 16), and the yield levelled off at higher Br- carrier 
concentrations. A maximum yield of radiobromouracil was obtained without 
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Br- carrier, but only 75% of the maximum yields of radio-bromotyrosine 
and cytosine were obtained under similar conditions. Points shown 
at zero Br- concentration were obtained using carrier-free radio-bromine. 
Figure (17) illustrates the influence of H2o2 concentration on the 
bromination labelling. The radiochemical yield of tyrosine and uracil 
exhibited yield curves \oJhich levelled off at a maximum concentratiol'l of 
H2o2 , while the radiochemical yield of cytosine dropped off at 
concentration above a peak value. 
The yields of the bromination labelling of tyrosine, uracil, and 
cytosine increased with time, Fig (18), until a maximum was reached 
after 5 minutes, and the curve then levelled off. 
Figure (19) shows the relationship betvteen chloroperoxidase 
concentration and the bromination yield. The maximum yield of bromouracil 
and bromocytosine was not affected as the concentration of chloroperoxidase 
increased above 0.6jJg. However, the radiochemical yield of bromotyrosine 
dropped when the chloroperoxidase was increased; the reason for this 
might be that the concentration of tyrosine in the saturated solution 
was low compared with the concentration of uracil and cytosine (which 
were used at 0.8 mg/ml), causing self bromination by the enzyme. 
Table (21) shows the optimum conditions and the radiochemical yields 
obtained for the enzymatic bromination labelling. 
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Chloramine-T Halogenation Labelling 
The half-reaction for the oxidation of halides are, 
- HOI + H+ -I + H20 + 2e E = -0.995 volt 0 
Br - + H20 HOBr + H+ + 2e 
- E ~ = -1.33 volts 0 
- + H20 
+ 2e - -1.49 volts Cl 
--
HOCl + H + E = 0 
The mechanism of iodination and bromination using chloramine-T is not 
known. It is thought that chloramine-T decomposes to form HOCl, which 
then reacts with iodide to produce HOI, which contains electropositive 
iodine. The oxidation potential given above indicates that HOCl should 
be able to oxidise bromide, although an intermediate step may be required 
for reaction, such as the formation of ICl. 
Bromide may undergo this reaction, because the electronegativity of 
bromine is less than.the electronegativity of chlorine. 
a. Iodination labelling. 
The chloramine-T iodination labelling was fast and high yields were 
obtained within 5 minutes, Table (15). Furthermore, the products could 
be obtained carrier free, i.e~ no I- carrier was needed to get the 
maximum yield as in the case of the lactoperoxidase method. The relationship 
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bet\-1een chloramine-T and the radiochemical yield \'/as not studied, becaus.e of 
the high yields obtained by using on~y 0~;75" mg· of chloramine~T,. 
b. Bromination Labelling. 
The chloramine-T bromination ·method \>Jas also fast, but it was 
strongly dependent on the concentration of chloramine-T in the reaction 
mixture, Fig. (20). The radiochemical yields dropped as the concentration 
of chloramine-T increased. Here again, neither uridine nor histidine 
reacted \-.rith Br-80m. 
The optimum conditions and the radiochemical yields of the 
chloramine-T bromination labelling are given in Table (22). 
The halogenation of other biomolecules was attempted with no success. 
They are cytidine, 4,6- dihydroxy pyrimidine, thymidine, thymine, 
hydroxytyramine, guanine, and adenine. Both thymidine and thymine have 
a CH3-group occupying position number 5 in the ring (the expected position 
for the X+ electrophilic substitution), but the reaction showed that 
x+ \'las not capable of substituting the CH3-group or of reacting at 
the 6th position under the conditions employed. 
Tryptophane reacted with bromine (but not with iodine) in the presence 
of chloroperoxidase only, to form a product other than the expected 
product (bromotryptophane). Identification of the product was not 
successful. Tryptophane was completely destroyed upon reaction with 
chloroperoxidase as judged by the disappearance of its normal spectrum. 
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0 
Thymine 
.HO(~ 
HO 
4,6 Dihydroxy 
pyrimidine 
CH2 0H 
!iO-f\ 
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~Che . spectrum of the product of the chloroperoxidase reaction of 
tryptophane \d th Br-80m showed peaks· at 252 and· 51'7 nm , the normal 
tryptophane spectrum has absorption peaks at 280 and ·28~nm • It is 
assumed that the indole ring has been degraded. 
the loss of the characteristic uv spectrum. 
This \.rould account for 
Chlora."'line-T and Enzymatic Halogenation 
The yields of halogenated molecules, obtained by both enzymatic 
and chloramine-T are shown in the follovring table. 
Table 23 
Enzymatic and chloramine-T halogenation yield 
Label (%) 
Chloramine-T Enzymatic 
Compound I-125 Br-~Om I-125 Br-80m 
Tyrosine 86 65 85 83 
Uracil 95 83 8~ 89 
Cytosine 85 76 77 68 
Uridine 75 92 
Histidine 86 90 
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Comparing the results in the table, shO\.,rs that in the iodination 
process no major differences were observed in the radiochemical yields 
of tyrosine, cytosine, and histidine. However, in the case.of uracil, 
the chloramine-T labelling was slightly more efficient than the enzymatic 
labelling.On the other hand, the enzymatic labelling of uridine was more 
successful. 
The brominatian yields for tyrosine were higher when labelled 
enzymatically, while in the cases of uracil and cytosine, the two methods 
gave similar results.· 
\Vhile both methods have proved to be effective, chloramine-T 
labelling has the advantage that no carrier is required~ Conversely 
the use of carrier ,.,as essential for the enzymatic iodination labelling, 
and, further, the brominated yields were also improved. 
Chromatographic Separation. 
Two methods for the separation of the radio-halogenated biomolecules 
from the reaction mixture were used, gel filtration using sephadex G-10 
and reverse phase HPLC. Both are simple and efficient methods, although 
the HPLC technique offered greater. advantages. 
No separation between halogenated biomolecules and halogens was 
achieved \'lhen distilled water \-/as used as the eluant on a sephadex G-10 
column. Hov1ever, good resolution was obtained when a phosphate buffer 
solution (0.01H) pH 7.0) ,.1as used. This method has the follo,.Ting 
disadvantages; 
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1. The presence of the buffering salts is undesirable in most cases. 
2. The separation of biomolecules and halogenated biomolecules is not 
satisfactory as is shown in Table (9). 
3. Elution time is lengthy (45-60 minutes). 
As a result,the ·use of a sephadex G-10 column is not recommended, 
particularly when short-lived isotopes are employed. 
Reverse phase high pressure liquid chromatography is an excellent 
method for the separation and analysis of the halogenated product. This 
is due to the following reasons: 
1~ HPLC offers a high resolution for the separat~on of halogens. 
biomolecules, and halogenated biomolecules, so that a pure radio-
labelled product is obtained at high specific activity. 
2. Distilied toJater is used as an eluant; .. with the result that the 
products are completely free of buffering salts. 
3. Elution time was short. A typical separation could be completed in 
5 - 10 minutes., \oJhere a suitable pump is used. 
4. Quantities (in mg level) may be successfully separated when a 
preparative column is used. 
The HPLC is an ideal method for the separation of labelled biomolecules 
from the reaction mixture, especially when short life radioisotopes are 
involved. 
Since our primary interest was in obtaining the halogenated compounds 
in aqueous solution, most of the experiments were performed using distilled 
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·.·:ate?.!' as the eluant. Host of the separation of mixtures occurred readily 
ani the qunntities of material involved could be increased where the 
solubili ties allO'.ved. The r1ost difficult separation was that involving 
uracil and bromo or iodo-uracil, .and the chromatogram obtained for 
uracil/iodo-uracil/iodide ion mixture is sho\vn in Fig. (7). The peak 
shapes obtained for the uracil-containing compounds \vere much broader 
than those observed for other sa'Tiples \·li th similar retention volumes. 
In spite of this, the separations vTere sufficient to allo\v collection 
of the halogenated product. 
The retention volumes of all compounds studieQ decreased as meth~~ol 
was added to the eluant. Typical of the effect of added methanol waS 
the variation of retention vol~~e of iodocytos~ne with eluant composition, 
sho~m in Fig. (21). Host of the separations,in practice, were acceptable· 
using tvleOH/H2o up to about 20% MeOH, and 20/80 HeOH/H20 eluant was 
particularly useful 'for iodotyrosine (see Table (?)).separation during 
radiolabelling experiments. 
Other chromatographic columns were tried, but proved to be unsuitable. 
+ + ( - - ) Do\.;ex 50 x 8 (H and Na forms) and Dmvex 1 x Cl and OH forms tended 
to retain most of the radioactive I-125. Also the peaks obtained from 
these columns were broad and exhibited tailing, although a \vide range of 
eluting reagents Here employed. Zerolit -226 (H+form) columns gave poor 
resolution. 
100 
E 
' 
(l) 
E 
=.; 
-0 
> 
c 
0 
·-~ 
c 
CD 
-o-
CD ,._ 
tooj 
I 
sot 
I 
~ 
I 
I 
20 
I 
10 
% methanol 
Fig. 21. Variation of retention volume of iodocytosine with eluent 
composition. 
101 
20 
Conclusion 
This work has dealt 111ith investigation of the optimum conditions 
required for the halogenation of tyrosine, uracil, cytosine, uridine, 
and histidine using unconventional labelling methods, i.e. enzymatic 
catalysis and chloramine-T. Reverse phase HPLC was used for the 
separation of the products and proved to be an efficient rapid method 
(better than gel filtration), giving pure labelled compounds in aqueous 
solution free from buffering agents and parent molecules. This method 
has been especially useful - due to its speed ~ in dealing with short-
lived isotopes such as. I-128 Ct1 = 25 min) and Br-80m (t1 = 4.3hrs). 
2 2 
The iodination of tyrosine, uracil, cytosine, uridine, and histidine 
and the bromination of tyrosine, uracil, and cytosine were carried out 
successfully. The labelling technique was fast and the products were 
pure and of high specific activities. Similar results, in most of the 
cases studied, were obtained for both enzymatic catalysis and when using 
chloramine-T. 
Although the use of enzymatic catalysis and chloramine-T has been 
employed in labelling of large molecules (such as proteins), no previous 
attempt has been made to label small biomolecules such as pyrimidines 
(particularly uracil, cytosine, and uridine). 
The isotopes used in this \'fOrk, i.e. Br-80m and I-125~ served as a 
model. Ho\·Jever, Br-77 and I-123 \-rould be more desirable isotopes for 
use in in vivo nuclear medicine because of the low radiation doses which 
patients would receive from such nuclides. 
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TABLE 1. Coefficients of variation in four energy bands of 131 I for the redistribution 
effects after oral administration 
Coefficient of variation (%) for 
Subject w 1()(}-280 130-430 220-430 300-420 
no. (kg) (aJ'H)I/2 
I 49 0.55 
2 46 0.52 
3 47 0.53 
4 41 0.51 
5 46 0.54 
6 .81 0.73 
7 53 0.57 
8 58 0.60 
9 76 0.74 
10 56 0.61 
11 54 0.60 
12 69 0.665 
13 60 0.61 
the radionuclide and the body build parameters, and the 
results usually difficult to generalize. 
In the present investigation, it is seen (Table 1) that the 
wide energy bands give minimum variation in eight out 
of 13 cases, photopeak band-in four and Compton band 
in one only. There is, however, no suitable relation between 
the minimum variation energy band and (»JH)1'2. Since 
the optimized geometrical conditions have been used,l3l it 
. is possible to obtain coefficient of variation less than I 0% 
in all cases (Table 1 ). The difference in coefficient of vari-
ation for different energy bands not being always signifi-
cant, a wide energy band is, however, a suitable com-
promise. This is in contrast to observation by Gibbs17l that 
assays based on Compton band are less dependent on the 
body build and redistribution for his geometrical set-up 
consisting of eight Nal (TI) detectors. An analysis of this 
report and other reports subscribing to this view<5·7l shows 
that Compton band has merit for wide angle geometries 
approaching 4x geometry. The range of application of 
Compton band seems to be limited. 
The choice of 1311 for this investigation was based on 
the fact that it never gets uniformly distributed and 
extreme changes in distribution in 2 h provide an ideal 
situation as compared to 42K which has often been used 
and is uniformly distributed. Second, the energy of 364 keY 
is suitably placed in the range 1()(}-500 keY in which most 
of the clinical radioisotopes lie. Investigations on 51Cr and 
169Yb also lead to similar inferences for the spectral energy 
band. Since the observation during 2 h covers conditions 
of extreme variations of radionuclide in the body, the coef-
ficients of variation derived represent a satisfactory index 
of the averaged variation for the particular energy band. 
Nuclear Medicine Department and M. M. REHANI* 
Biomedical Engineering Division, A. K. BASU 
AI/ India Institute of S. K. GuHA 
Medical Sciences, 
New Delhi, 
India 
* Pres~t address: Dr. M. M. Rehani, Lecturer, Depart-
ment of Biophysics, Panjab University, Chandigarh-14, In-
dia. 
keY keY keY keY 
4.9 2.1 3.3 5.4 
5.9 4.5 3.2 1.1 
3.9 1.02 0.7 3.8 
5.0 2.7 1.8 2.6 
4.7 7.6 6.6 3.7 
8.4 9.4 9.5 10.6 
5.9 3.3 2.9 1.8 
4.0 2.3 2.7 4.4 
5.9 2.2 1.4 4.3 
6.5 2.2 4.9 7.1 
8.2 10.3 4.1 3.8 
4.8 9.03 9.7 3.7 
8.7 2.4 1.5 6.4 
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The Preparation and Isolation 
of Carrier-free Radio-iodo-
tyrosine 
A method of rapidly preparing and isolating radio-iodotyr-
osine has been developed and tested using 1251 and 1281. 
The technique produces iodotyrosine in aqueous solution, 
but free of buffer salts and iodide ion. 
A GREAT deal of work has been reported on the radio-
iodination of molecules of biological and medicinal impor-
tance including amino acids, polypeptides and proteins. 
Methods generally useful include iodination using iodine 
monochloride,< 11 Chloramine-T,<21 lactoperoxidase<31 and 
immobilized lactoperoxidase<41 and electrolytic iodina-
tion.<51 For the larger iodinated molecules, such as the 
748 Technical notes 
!-tyrosine tyrosine 
~ ~ 
300 200 100 0 
Elution volume I ml 
FIG. I. Ultra-violet absorption obtained after HPLC sep-
aration of iodide, tyrosine and mono-iodotyrosine on 
25 x I cm 10 Jlm ODS Spherisorb column using water as 
eluate. Flow rate was -IOmlmin- 1• 
polypeptide hormones, purification from iodinating re-
agents, buffering solutions, etc. can be achieved readily 
using gel filtration. However for smaller molecules, such 
as iodinated amino acids,l 61 purification is more trouble-
some, usually requiring ion-exchange or adsorption 
chromatography which in turn introduce difficulties, such 
as those of isolating the labelled compound from the elut-
ing agent. 
As part of a research program on the production of 
carrier-free labelled molecules, we have developed a 
method for the rapid preparation and isolation of radio-
iodinated mono-iodotyrosine which results in carrier-free 
product in aqueous solution completely free of buffering 
agents and other compounds. The method is fast enough 
to be useful with 1281 (t 112 - 25 min), although most of 
our experiments have been performed using 1251 (t112 - 60 
days). The main advantage of the method is that mono-
iodotyrosine is separated into distilled water rather than 
into a buffered salt solution as would be required in more 
conventional separations. 
Experimental 
Radio-iodotyrosine was formed by the reaction of 
radio-iodine in aqueous solution with tyrosine in buffered 
solution. The reaction was catalysed by lactoperoxidase 
immobilized on Sepharose-4B, in the presence of H20 2, 
and phosphate buffer (pH 7). After the appropriate reaction 
time, reaction was terminated by addition of aqueous 
sodium metabisulphite, the immobilized enzyme separated 
by centrifugation, and the aqueous layer loaded on to a 
reverse-phase high-pressure liquid chromatography 
column from which the components were eluted using dis-
tilled water. 
The materials used were: 
1251, carrier free, in NaOH solution; obtained from the 
Radiochemical Centre, Amersham; 
0 
..J 
... 
)-
8 
REACTION 
16 24 
TIME I MIN. 
FIG. 2. Variation in radiochemical yield with reaction time. 
Other conditions: 2 Jlg lactoperoxidase, 2 X w- s mole Kl, 
and 10- 5 mole H 20 2• Total volume -1 ml. 
1281, generated by neutron bombardment of ethyl iodide, 
followed by extraction with water; 
L-tyrosine, BDH, Chromatographic Grade; 
3-mono-iodo-L-tyrosine. Sigma Chemical Co.; 
Lactoperoxidase, Boehringer Mannheim; 
and 
CNBr-activated Sepharose-4B, Pharmacia. 
The chromatography column was a I x 25 cm column 
packed with 10 J1m O.D.S. Spherisorb (Phase Separations 
Ltd.) and was supplied by Anachem Ltd. The chromato-
graph was an Altex model 300 liquid chromatograph with 
a u.v. biochemical monitor. The eluant from the u.v. detec-
tor was passed into a hollow Teflon helix confined in the 
well of a Nal(fl well-crystal scintillation detector so that 
the eluant activity could be monitored. Samples were intro-
duced to the chromatograph as 0.5-ml aliquots using an 
Altex model 905 sample injection valve. 
0 
..J 
... 
>-
1•0 
0·6 
0·2 
,-~, 
I. • ~ ... 
I ' I 
I 
4 8 12 
K I CONCENTRATION I 10"5 MOL 
FIG. 3. Variation in radiochemical yield with total r- con-
centration. Other conditions: 4 J1g lactoperoxidase, 
10- 5 mole H 20 2, and reaction time 15 min. Points shown 
at zero 1- concentration were obtained using carrier-free 
radio iodine. Total volume - I ml. 
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Experiments were performed using a wide variety of re-
agent concentrations, but the quantities used in a represen-
tative case were: 
1251, 25 td of solution containing 100 JlCi/ml Nal (in-
cluding carrier when used), IOJll of 2 x 10- 3 M solution 
tyrosine, I ml of solution in 0.01 M phosphate buffer 
(pH 7), and 0.1 M NaCI. This solution was saturated in 
tyrosine at 25°C. Hydrogen peroxide, 10 jd of 10- 3 M solu-
tion. 
Immobilized lactoperoxidase, 80 Jll of a suspension of 
beads in water, containing 0.2 ml of beads (fully swollen) 
per ml of suspension. The enzyme was immobilized using 
the method of David,141 and the concentration of lactoper-
oxidase per m! of swollen beads was chosen to be· the 
optimum found for the iodination of proteins, i.e. 
50 jlgml- 1• 
Results and Discussion 
The chromatographic separation of iodide, tyrosine and 
mono-iodotyrosine as· recorded by u.v. absorption are 
shown in Fig. I. In this case the flow rate of water was 
- 10 ml min - 1, although, for preparative purposes, the 
flow rate could be increased up to 100 ml min - 1 without 
losing the separation. Di-iodotyrosine could also be separ-
ated under the same conditions, giving a retention volume 
of -280ml. 
The yield of 1251-mono-iodotyrosine, defined by 
activity of 1251-mono-iodotyrosine 
total 1251 activity used 
was determined as a function of reaction time and total 
I- concentration (including carrier 1- when present). The 
results are shown in Figs. 2 and 3. One or two points 
on each curve were repeated using 1281 or much higher 
specific activities of 1251. No significant deviations from 
the results shown in the figures were observed. 
• From whom further information may be obtained 
There are· several advantages in this iodination tech-
nique: 
(I) carrier-free mono-iodotyrosine can be obtained; 
(2) unreacted r can be recycled; 
(3) the iodinating catalyst is removed from the system 
before the chromatographic separation stage, thus mini-
mizing contamination of the chromatography column. 
The separation method also has clear advantages over 
the normal separation procedures: 
(I) carrier-free mono-iodotyrosine can be obtained; 
short-lived 1281; 
(2) the desired product is obtained in distilled water, free 
from the buffer salts, etc. which would be present following 
an ion exchange separation. 
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The Labelling of Small Molecules 
with Radioiodine 
U. A. M. HADI, D. J. MALCOLME-LA WES and G. OLD HAM . 
Nuclear Chemistry Laboratory. Loughborough University of Technology. Loughborough, Leicestershire, U.K. 
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Radioiodination of uracil, cytosine. uridine and histidin~ by the use of immobilised lactoperoxidase 
and the Chloramine-T method has bet:n investigated. The iodinated productsxhave been separated 
using reverse phase hplc. Iodination efficiencies are high with both methods. 
THERE has been considerable interest in the use o( 
radiolabelled pyrimidines and related molecules m; 
biochemistry and medicine. As judged by the number; 
of published reports on the labelling of these mater-; 
ials, the most widely used labels have been radio-! 
isotopes of iodine. Methods of producing the radio-j 
iodinated compounds have included isotopic: 
exchange.111 for example between 1311 and iodocyto-; 
sine at pH 7, IOO'C for 2 hr, or direct iodinationP1: 
for example of uracil by refluxing in CHC13/HN03 1 
with radioiodine solution. Isotopic exchange is clearly! 
inappropriate when high specific activity product is! 
desired. whereas refluxing high specific activity: 
radioiodine solutions is an undesirable procedure for: 
many laboratories.. . I 
· As part of a research programme on the synthesis! 
of carrier free latJelled compounds we have examinedl 
techniques of synthesising radioiodinated compounds: 
in high radiochemical yield, and of isolating thej 
labelled product in aqueous solution-free from thei 
buffering agents normally present in ion exchangei 
separation systems. We report here a comparison of\ 
enzymatic iodination and chloramine-T iodination for j 
the production of iodouraci~ iodocytosine, iodouri-
1
1 
dine, and iodohistidine, structure 1-4 respectively. , 
NH2 
• I 
1 =(CH2·CH 
',-__ I 
I COOH 
N~N 
(I) (2) (3) (4) 
- Most of th.: results have been obtained using the 
isotope. 1251 (t 112 = 60 days), although the methods of. 
iodination are sufficiently rapid to be u>eful for short-
lived isotopes such as 1281 (t I!! = 25 m in), and we 
have repeated several cxp.:riments using this 
radion uclide. 
EXPERIMENTAL 
Two general procedures for producing the labelled· 
compounds 1-4 were used. The first involved reacting: 
the non-iodinated parent compound in buffered: 
aqueous solution with radioiodine, the reaction being: 
catalysed by the enzyme lactoperoxidase (immobilised 
on Sepharose-4B) in tpe presence of. H 20 2•131 After: 
an appropriate reaction time any unreacted radio-; 
iodine was reduced to iodine by the addition of 
aqueous sodium metabisulphite, the immobilised 
enzyme separated by centrifugation, and the reaction; 
product isolated by high pressure liquid chroma-' 
tography (hplc) using distilled water as the eluant. 
The quantities of materials used for the preparations' 
varied from experiment to experiment, but. representa-; 
tive values were similar to those used in our earlier: 
synthesis of radioiodotyrosine.'41 · j 
The second iodination procedure was an adap-; 
tation of the well known Chloramine-T method'51 for: 
I 
iodinating proteins. In each case to 500 jlg of starting: 
material in 500 Jd of 0.01 M phosphate buffer (pH: 
7), -2~tCi of 1251- solution (IOO~tCifml) and 75pl; 
of Chloramine-T solution (IOmgfml} were added.! 
After a reaction time of five minutes reaction was: 
terminated by the. addition of I 00 Jll of sodium meta.' 
bisulphite solution (20 mglml), which also ensured:· 
that all unreacted 1251 was in a reduced state before: 
chromatographic analysis. For the Chloramine-T; 
reactions the radioiodide was used carrier free. \ 
The materials used were: 1251, carrier free, inf 
NaOH solution (The Radiochemical Centre). 128I,l 
generated by neutron bombardment of ethyl iodide: 
followed by extraction with water. Undine (99%). his-: 
tidine (9S%l and 5-iodo-uridine were obtained from' 
Aldrich Chemical Company. Cytosine (98%) from 
B.D.H. Limited, and uracil from Halewood Chemi-
cals. Samples of inactive iodouracil and iodocytosine 
were prepared by the method of JoH:-.:so:-; and 
JOH:"S.161 . 
L:lctoperoxidasc (from Cow milk) was supplied by 
2 U. A. l\1. Hwli. D. J. Malcolme-Lawes and G. Old/rum 
Boehringer l\fannheim. and CNBr-activated Sephar-
ose-4B by Pharm::~cia Limited. The Lactoperoxidase 
was immobilised on the Sepharose-4B using the 
method described by David.171 The concentration of 
enzvme per m! of swollen beads was -50 pg ml- 1,: 
the' optimum value reported for protein iodination.! 
Chloramine-T (X Chloro-4-toluene sulphonamide, 
sodium salt) was obtained from Koch Light Labora-
tories Limited. 
The high pressure liquid chromatographic separ-
ations were carried out on an Altcx Model 300 chro-
matograph fitted with a u.v. (254 nm) biochemical 
monitor. The chromatography column was a 
1 x 25 cm column packed with 10 11m ODS-Spheri-
sorb (Phase Separations Limited) and was supplied 
by Anachem Limited. After monitoring for u.v. · 
absorption the eluant was passed . through a hollow 
PTFE helix held in the well of a Nal(fl well-crystal 
scintillation detector. The samples were loaded onto. 
the chromatography column using an Altex Model · 
905 sample injection valve fitted with a 500 pi loop .. 
RESULTS AND DISCUSSION 
H202 concentration, J0-5M 
FIG. 2. Variation in radiochemical yields following enzy-
matic iodination or uracil ( x) and cytosine (0). with H20 2 
concentration. Other conditions: Uracil-40 pg. Jactoper- · 
oxidase-4 Jtg, in I m!. Phosphate buffer, 2 X w-6 M Nal. 
Cytosine-200 Jtg. lactoperoxidase-4 pg. in 1 ml ph os-: 
phate buffer, 4 X w- 6 M Nal. Reaction times 20min 
throughout · 
The chromatographic separations of the reaction :o:? 
mixtures were performed using distilled water as the ~ 0 6 
eluant. All the separations were straightforward and 
the differences in retention between the. iodinated 
product and other materials were sufficient to allow 
easy collection of the desired product. A typical chro-
matogram is that obtained by u.v. absorption for the 
separation of a mixture of iodide, cytosine and iodo-
cytosine, and is shown in Fig. 1. When a radioisotope 
was present the eluant activity gave similar peak 
shapes for the appropriate active components. 
I 
!-Cytosine I 
Cytosine 
Elution volume, ml 
FIG. I. U.V. absorption following hplc separation of (inac-
tive) iodide. C}tosinc and iodocytosine. Flow rate 
!Oml. min- 1• 
8 i 
Nai concentration, 10"6M ! 
- J 
FIG. 3. Variation in radiochemical yields following enzy-· 
matic iodination or uracil ( x) and cytosine (0) with Nal, 
concentration. Other conditions: Uracil-40 pg, lactoper-: 
oxidase-4 pg. in I m!. phosphate buffer, 1.2 X w-s M 
H20 2• Cytosine-200 Jtg. lactoperoxidase--4 pg. in I m I: 
phosphate buffer 3 X w-s M H202. Reaction times' 
20 min throughout j 
10 20 
Time, min 
I 
I 
I 
' I 
I 
i 
I 
30 l 
' 
' 
.. 
FtG. 4. Variation in radiochemical yields with reaction 
time for cnzymatic iodination or uracil ( x) and cytosin.: 
(0). Other conditions: Uracil--40 pg. bctopcruxiJ-
asc--4 Jig. in lml phosph:ttc buffer, 2 X w- 6 M Nal. 
1.2 X w-' M H202. Cytosine-200 Jtg. l:tctoperoxid-
asc-4 Jig. in I ml phosphate butTer. 4 X w-h M Nal. 
5 X w-s M HzOz. 
Tlze labelling of small molt'c!ll<'s 3 
TABLE I. Optimised product yields for enzymatic iodination 
Product Radiochemical Reaction Concentrations• 
yield(%) time (min) (10- 6 M) 
Nal H202 
Iodouracil 83 20 2.0 12.0 
lodouridine 92 30 120 30.0 
lodocytosine 77 20 4.0 50.0 
Iodohistidine 90 20 4.0. 30.0 
lodotyrosinet 85 20 60.0 10.0 
• Beads holding 4 Jlg Lactoperoxidase used throughout. 
t From Reference 4. 
Radiochemical yields from the iodination reactions 
were obtained as 
activity of iodinated product 
total activity used. 
Enzymatic iodination 
The radiochemical yields of products 1--4, obtained 
using enzymatic iodination, were measured under dif-, 
ferent reaction times and conditions. The results for : 
1251-iodouracil and 1z5I-iodocytosine are collected in' 
Figs. 2-4. The yields are estimated to contain errors· 
of less than ± 3%. · 
In Fig. 2 the radiochemical yield is shown as a· 
function of H20 2 concentration in the reaction mix-
ture. Clearly the highest yield of iodouracil is. 
obtained with a lower H20 2 concentration than that, 
required for iodocytosine production over the same. 
reaction time (20 m in~ Figure 3 shows the variation· 
in radiochemical yield with the total iodide concen-. 
tration (including carrier), and again the requirements· 
for the two reactant species are quite different. , 
The time variations of the radiochemical yields at· 
optimised H20 2 and Nai concentrations are shown 
1 
in Fig. 4. In general similar reaction times were 
necessary for all reactants studied here and tyrosine. 
The optimum yields of iodinated products obtained 
in this work are collected in Table l, along with the 
appropriate reaction conditions. 
Some of the labelling experiments were carried out 
using .much higher activities of carrier free 1251, or 
using the short lived 1281 V'(ith carrier present. Within 
the error limits given above no significant difference 
in yield was found for the different isotopic composi-
tions. 
Chloramine- T iodination 
The radiochemical yields obtained using the Chlor-
amine-T method are summarised in Table 2. Again 
the error limits may be taken as ± 3%. 
TADLE 2. Radiochemical yield from chloramine-T 
iodinations 
Product 
lodouracil 
lodocytosine 
Iodouridine 
Iodohistidine 
lodotyrosine• 
• From Reference 4. 
Radiochemical yield (%) 
95 
85 
75 
86 
86 
CONCLUSION 
The results indicate that both methods of iodina·
1 
tion tested provide satisfactory means of synthesising 
the radioiodinated compounds 1-4. The use of reverse • 
phase hplc offers a rapid and efficient method of 
separating the desired labelled product into aqueous 
solution free of buffering agents. : 
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APPENDIX III 
Chronatographic separation of some small 
molecules fron their halogenated analogues 
by 
U. A. M. Hadi, D. J. Malcolme-Lawes and G. Oldham 
Nuclear Chemistry Laboratories 
Loughborough University of Technology 
Loughborough~ Leicestershire. 
?he semi-preparative scale separation of tyrosine~ uracil, 
cytosine, uridine and histidine from their bromo- and iodo-analogues 
~as investigated using reverse phase h.p.l.c. Successful separations 
"..tere ·achieved using pure i-later as eluant. 
J.of Chromatography 
Volume 156(2), 350-353 
- 1 -
s~all molecules such as amlno acids, pyrimidines and related compo1mds are 
frequently labelled with radioisotopes of iodine or bromine for studies in 
biochemical or medicinal research1 - 5 . In general the labelling techniques 
used produce a mixture of the parent compound and the halogenated product 
which requires separation on a preparative or semi-preparative scale before 
the h~ogenated material is available for use. The most commonly used 
metcod of achieving such separations has been some form of ion exchange 
chromatography s, although this has the disadvantage that the desired 
product is obtained in a solution of the salts used for buffering. 
\·le have developed semi-preparative, reverse phase h.p.l.c. separations for 
a nunber of small biomolecules and the non-radioactive iodinated and 
brominated analogues, which can be used for the isolation of the halogenated 
material in aqueous solution free from the buffering agents mentioned above. 
\·Te report here on the separations of tyrosine, uracil, cytosine, uridine. 
and histidine from their mono-iodo- and mono-bromo-analogues. 
- 2 -
Exnerinental 
3-ioiotyrosine, 5-bromocytosine, 5-bromo-uridine, 5-bromouracil and 
5-iodouridine were obtained COffiffiercially (see below). Samples o~ the other 
halogenated materials were obtained by warming the halogen and the parent 
conpoU!ld in NaOH solution, ~allowing the method o~ Johnson and Johns6. 
Tne reaction mixtures, or mixtures produced by mixing samples o~ parent 
conpound and a halogenated analogue, were then analysed on a semi-preparative 
scale by h.p.l.c. 
Tne chromatographic separations were per~ormed on an Altex model 300 
cr·t~fDL. . 
chro~ato~~itted with a u.v. (254 nm) bioche~ical monitor. The collimn 
was a 25 x l ems. column packed with 10 ~ ODS Spherisorb (Phase Separations) 
a::.1d supplied by Anachem Limited. The eluant was distilled water or 
H2 0/£.!eOH mixtures as described below. Samples were o~ ~ixed· volume (0.5 ml) 
and were loaded using an Altex model 905 sample injection valve. 
~f;aterials 
Uridine (99%), Histidine (98%), 5-bromouridine and 5-bromocytosine were 
obtained ~rom P~drich Chemical Co. 
5-broco~acil and 3-iodo-L-tyrosine were obtained ~ram Sigma. 
~Jrosi~e (Chromatographic grade) and Cytosine (98%) were obtained ~rom 
B.D.H. LiMited. 
Uracil was obtained from Hale1wod Chemicals. 
P~l of the above materials '\;ere found to be sufficiently pure on chromatographic 
analysis for our purposes and were used without further purification. 
- 3 -
Results and Discussion 
Tne individual compounds or preparation mixtures were chromatographed ~n 
water ~r H20/MeOH eluants by loading 0.5 ml samples (~50 _~g of compound ~n. 
water) onto the column. In most cases an eluant flow rate of ~10 mls min-1 
was used, and in all cases the column was operated at room temperature 
(~ 20° C). After calibrating the system by obtaining retention volumes 
for the individual materials the separations were checked on samples 
containing _both the parerit compound and its halogenated analogue. 
Chromatographic senarations using water eluant , 
Since our p~1mary interest was 1n obtaining the halogenated compounds in 
aqueous solution, most of our experiments were performed using distilled 
water as the eluant. Tne retention volumes obtained for each individual 
compound studied are collected in Table 1. ·Most of the separations of 
mixtures occurred readily and the quantities of material involved could 
be increased where the solubilities allowed. The most difficult separation 
r-
was that involving uracil and bromo- or iodo-uracil, and the chromatogram 
obtained for a uracil/iodo-uracil/iodide ion mixture is shown in Fig. 1. 
The peak shapes obtained for the uracil-containing components are much 
broader than was observed for other samples with similar retention volumes. 
In spite of this the separations were sufficient to allow collection of 
the halogenated product. 
- 4 -
Variation of retention with methanol co:1centration 
?ne retention volumes o:f all compounds studied decreased as methanol was 
added to the eluant. Typical of the effect o:f added methanol was the 
variation of retention volume o:f iodoc)~osine with eluant composition, shown 
in Fig. 2. In practice most o:f the separations were acceptable using 
·~·1eO:H/H20 up to about 20% MeOH~ and "\·rere found particularly useful for 
iodotyrosine separations during radiolabelling experiments. 
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FiF;Ure Cautions 
Fig. 1 Separation of I-, uracil and 5-iodo-uracil on Spherisorb 
ODS column using water eluant. Flow rate~ 10 ml min-1. 
Fig. 2 Variation of retention volume for iodocytosine with methanol 
concentration of i'·1eOH/HzO eluant. 
~-
'l'able l 
Retention volumes obtained us1ng distilled water eluant, 
~10 mls min-1 and 25 x l ems ODS-Spherisorb, 10 ~' column. 
Cor:mound (a) Retention volume/ml. 
'I'yrosine 45 
3-bro~o-TYrosine 82 
3-iod.o-'i'yrosine 220 
Uracil 25 
5-bror::o uracil 44 
5-iodo uracil 6o 
Uridine 26 
5-bro:J.o uridine 84 
5-iodo uridine 35 
Cytosine 30 
5-bror::o cytosine 82 
5-iodo cytosine 80 
Histidine (b) 35 
5-iodo histidine 55 
(a) Samples rv50 ~g 1n 0. 5 ml "1-rater 
(b) Obtained by fraction collection and u.v. ~bsorption measurements 
at 200-210 n.rn. 
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APPENDIX IV 
RAP ID R~D I OHALOGENATION OF SMALL MOLECULES 
BY 
UsAMA A. r·1. HADIJ DAVID j I MALCOU1E-LA\~ES AND 
GRAHA~1 0LDHAM 
NUCLEAR CHEMISTRY LABORATORY 
. . . . . . ....... . 
LoUGHBOROUGH UNIVERSITY OF TECHNOLOGY 
LEICESTERSHIRE 
1. INTRODUCTIO~ 
RADIOHALOGENATE6 AMINO ACIDS AND PYRIMIDINES ARE OF INTEREST AS 
POSSIBLE RADIOPHARMACEUTICALS AND AS INTERMEtiiATES IN THE 
PRODUCTION OF OTHER LABELLED MATERIALS, MOST OF THE REPORTED 
~1ETHODS FOR THE PREPARATION OF RADIOHALOGENATED COMPOUNDS HAVE 
. ''! 
INVOLVED EITHER HALOGEN EXCHANGE LABELLING OR DIRECT LABELLING 
OF A NON-HALOGENATED MATERIAL BY REACTION WITH AN ELEMENTAL 
. -. . .. -.. . . 
HALOGEN, SUCH METHODS HAVE DISADVANTA~ES IN THE AREAS OF REACTION 
TIME (WHEN THE USE OF SHORT-LIVED RADIONUCLIDES IS CONTEMPLATED)) 
PROCEDURAL SAFETY AND CONVENIENCE OF SEPARATION OF THE DESIRED 
PRODUCT, 
WE HAVE DEVELOPED SAFE AND RAPID PROCEDURES FOR RADIOHALOGENATING 
A NUt·1BER OF C0~1POUNDS \"/HICH CONTAIN AN AROMATIC SYSTEM AND FOR 
SEPARATING THE LABELLED PRODUCT INTO AQUEOUS SOLUTION. IN THIS 
PAPER WE CONFINE OUR ATTENTION TO RE~~~~~ O~TAINED USING 80MBR 
AND 1251 . (TH~SE ACTiN~ AS MODE~S FOR RADIONUCLIDES WHICH MAY BE 
OF MORE USE IN PRACTICE)) AND TO THE PRODUCTION OF HALOGEN-
LABELLED TYROSINE) URACIL) CYTOSINE) URIDINE AND HISTIDINE. · 
The abstract will be published in vo1.16 of the J. of labelled compounds 
and radiopharmaceuticals. 
2. 
Two PREPARATIVE PROCEDURES WERE INVESTIGATED: THE FIRST WAS AN 
ADAPTATION OF THE WELL-KNO~N CHLORAMINE-T METHODJ WHICH IS WIDELY 
USED FOR THE IODINATION OF PROTEINS; THE SECOND WAS AN ENZYMATIC 
METHODJ ALSO SIMILAR TO A PROTEIN IODINATION TECHNIQUEJ BASED ON 
. . . . .. . . . . . .. 
THE ENZYMES LACTOPEROXIDASE (FOR IODINATIONS) OR CHLOROPEROXIDASE · 
. . ~ - -. -. - -. . - . 
(FOR BROMINATIONS), fOLLOWING THE HALOGENATION REACTIONJ THE 
REACTION MIXTURES HAD A St1ALL QUANTITY OF SODIUt'l r-lETABISUL:PHITE 
. - . - .. . 
SOLUTION ADDED (TO ENSURE THAT ANY UNREACTED HALOGEN WAS FULLY 
- . . -
REDUCED) AND THE REACTION-PRODUCTS WERE SEPARATED BY SEMI-
PREPARATIVEJ REVERSE PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHY 
USING DISTILLED WATER AS THE t'lOBILE PHASE. 
I . 
--- --- ... - ...... --- . . ---
2.1 CHLORAMINE-T METHOD 
. . . . . . .. . . . 1 
To 500 UL OF A SOLUTION OF THE STARTING MATERIAL (1 MG·, ML- J 
.. . -- . 
EXCEPT TYROSINE WHICH WAS A SATURATED SOLUTION) IN 0.01 M 
. . 125 1 
PHOSPHATE BUFFER (pH 7)J ~2 u Cr OF 1- SOLUTION (100 u Cr ML- ) _ 
. . . . . . . . . 1 
WERE ADDED FOLLOWED BY 75 PL 0~ CHLORA~INE-T SOLUTION (10 MG ML- ), 
AFTER 5 MINUTES 100 uL OF_SODIUM META~ISULPH1TE SOLUJION (20 MG 
-1) ML WAS ADDEDJ TERMINATING THE REACTION AND REDUCING ANY 
UNREACTED HALOGEN TO HALIDE ION, 
A S H1I LAR PROCEDURE \~AS ADOPTED FOR THE BRot·li NATION REACTIONS 
BOnER-ALTHOUGH IN THIS CASE THE SPECIFIC ACTIVITY OF THE 
SOLUTION WAS CONSIDERABLY LOWER(~ 2 u(I ML-1), 
2.2 E~~ZYi•ATIC r-~ETHODS 
To 1 t·1L OF A SOLUTION (1 ~1G i-1L _, J EXCEPT TYROSINE \·JHICH \'/AS A 
SATURATED SOLUTION) OF THE STARTING MATERIAL ~HICH WAS 0.01 M IN 
PnOSPrU\TE BUFFER (pH 7,4) AND 0.1 f'1 IN f'JA(L.~ \•!AS ADDED 80 llL OF 
. . . .. .. . . - . - . . . .. 
A SUSPENSION OF FULLY-SWOLLEN SEPHAROSE BEADS (0.2 ML OF SWOLLEN 
. . -- - .... - . - .. . . 
BEADS PER ~1L OF BUFFERED SUSPENSION) ON WHICH LACTOPEROXIDASE HAD 
3 .. . . . .. .. .. . . .. ' .--. . . .. 
BEEN IMMOBILISED, 10 PL.OF 10- M H202 SOLUTION WAS THEN ADDED. 
. . -.. 
AFTER AN APPROPRIATE REACTION TIME (SEE BELOW) REACTION WAS 
TERNINATED AS DESCRIBED ABOVE AND THE SEPHAROSE BEADS CENTRIFUGED 
Dm~N. 
A SIMILAR PROCEDURE HAS BEEN USED FOR BROMINATIONS USING 
. .. . . . . . . . - ... 
CHLOROPEROXIDASE (AT PH 2.7) ALTHOUGH THE RESULTS REPORTED BELOW 
WERE OBTAINED USING THIS ENZYME IN AQUEOUS SOLUTION.· 
.. . -- . . . . . . . . . . 
2~3 CHROMATOGRAPHIC SEPARATIONS 
l . . . . ' . · ..... 
WHEN EACH REACTION HAD BEEN TERMINATED 500 PL ALIQUOTS WERE 
... 
LOADED ONTO A 25 X 1 CM COLUMN PACKED WITH 10 llM ODS SPHERISORB. 
THE COMPONENTS WERE ELUTED USING DISTILLED WATER AND THE ELUANT 
. . .. -
MONITORED FOR UV ABSORPTION (254 NM) AND FOR Y EMISSION. 
n 1 2 5 I ~~ I CT ) DETECTION EFFICIENCY FOR BY THE ~A L SCINTILLATION 
... 
DETECTOR WAS ~75%, 
foR THE PARTICULAR COLUMN WE USED THE ELUTION VOLUMES OF THE 
. . . . -. . ...... - . . . 
l1ATERIALS RELEVAi'l'T TO THIS \'/ORK \'lERE AS SH0\-1/N IN TABLE 1.~ AND 
. . .. . . . . . .. . . . . . . . 1". 
WERE ALL OBTAINED AT A FLOW RATE OF 10 ML MIN- • 
IN PRACTICE THE SEPARATION OF EITHER A BROMO-LABELLED PRODUCT 
OR AN !ODD-LABELLED PRODUCT FROM THE PARENT MOLECULE AND ANY 
. . - . . 
UNREACTED HALIDE WORKED WELL. A RATHER TYPICAL SEPARATION IS 
SHOWN IN fiG, 1, WHERE THE UV ABSORPTION CHROMATOGRAM FOR IODIDE 
IO~lJ TYROSINE AND IODOTYROSINE IS SHOI:IN. 
I -tyrosine 
~ 
. I 
I 
I 
J 
I 
i j ~ . i 
:I-_:--
1 -. . ... ·_ - . 
. . ~ 
I . 
f .. - .. -
300 200 100 0 
Elution volume I ml 
TABLE 1 
. . . 
ELUTION VOLUMES OF COMPOUNDS USED IN THIS WORK 
. - . - ~ . . 
COMPOUND ELUTION VOLUMEIML 
PARENT BRDr~lO-DER IVATIVE I ODO-DERIVATI VE 
TYROSINE 45 82 220 
URACIL .25 44 60 
CYTOSINE 30 82 80 
URIDINE 26 ~4 ".J. 35 
HISTIDINE 35 (A) 55 
(A) OBTAINED BY FRACTION COLLECTION AND UV ABSORPTION 
MEASUREMENTS AT 200-220 NM, 
3. REsUL rs AND DIscuss I m! 
3.1 [HLORAMINE-T HALOGENATIONS 
GOOD RADIOCHEMICAL YIELDS WERE OBTAINED FOR ALL THE IODINATION 
. . .... - ... 
REACTIONS CARRIED OUT IN THE PRESENCE OF CHLORAMINE-T. 
BROMINATION OF TYROSINEJ URACIL AND CYTOSINE WAS ALSO EFFICIENT~ 
ALTHOUGH NO PRODUCTS WERE DETECTED FROM BROMINATION REACTIONS 
. . . . .. - - . 
WITH URIDINE AND HISTIDINE. THE VARIATIONS IN RADIOCHEMICAL 
.. 
YIELDS WITH THE AMOUNT OF CHLORAMINE-T USED FOR THE SUCCESSFUL 
BROMINATION REACTIONS ARE SHOWN IN FIG. 2. 
(!) 
>-
~0-61 
(lJ 
..c 
.L) 
0 
u 
-u 
cr:Q.? 
I 
!~£------~. ------------~~----------------~---
0 o.?~ o.75 
Chloramine- T I mg 
FIG. 2 BROMINATION YIELDS FOLLOWING REACTION WITH 
---- '\ 0 URACIL; X TYROS I NEj • CYTOSINE. 
3.2 ENZYME CATALYSED HAI OGENATIONS 
THE IODINATIONS CATALYSED BY IMMOBILISED LACTOPEROXIDASE WERE 
NOT PARTICULARLY SENSITIVE TO THE QUANTITY OF ENZYME PRESENT 
. . . -.. . . -. . ... - .. 
OVER THE RANGE 0.5 - 6 PGJ ALTHOUGH THE RADIOCHEMICAL YIELDS 
.. . . - . -- -- . ·- . - . . -. . . . .. --. . -
DID VARY WITH REACTION TIME) AS SHOWN IN fiG, 3. IN MOST.CASES 
THE ENZYME CATALYSED IODINATION$ REQUIRED MORE TIME TO REACH 
.... - -- - ... - . . -- . - ...... - ... - . . - - . . . . . 
OPTIMUM RADIOCHEMICAL YIELD THAN THE CHlORAMINE-T REACTION. 
. .. .. . . . . . . - -- .. -. -- . . . -- ... - - . . . - ..... --. ---- . . .. 
IN ADDITION THE OPTIMUM RADIOCHEMICAL YIELDS FOLLOWING ENZYMATIC 
IODINATION WERE ~TRONGLY DEPENDENT ON THE AMOUNT OF INACTIVE 
. . . . - . . . . 
IODIDE PRESENT) AS SHOWN IN fiG.~ ·4 
>-
i .a 1 
I ..--;:~ I (" .. . 
. I 
. , I 
~~\ 
s 0-61r r /'/ 
E I 1 I 
· I I I (]) I I I 
-5 I I I I 
.._ I I 1 I 
I I I I 
u I If 1 
0 I /1 I 
0 ? · t/ I 0:: . ..._ -jl /i I· 
1!tt I 
'lii/ 
,y I 
I]! 
'"' V 
0 
. 
10 20 
Time I min. 
30 
FIG. 3 IoDINATION YIELDS FOLLOWING ENZYME CATALYSED 
REACTION \•!ITH 0· URIDINE; ·• HISTIDINE; 
Q URACIL; X TYROS I NE; l3J CYTOSINE I 
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Tu= BEHAVIOUR CONTRASTS WITH THAT OBSERVED FOR THE BROMINATION 
. . . . .. - .... -. - -. ·- . 
REACTIONS CATALYSED BY 0.6 - 2.2 ~G OF CHLOROPEROXIDASEJ WHERE 
IT \·/AS FOUND THAT THE RADIOCHB,1ICAL YIELDS REACHED THEIR OPTIMUM 
- -· .. . . - .. - - . .. . . 
VALUES MORE RAPIDLY (fiG, 5) AND THAT THESE YIELDS WERE NOT VERY 
- . . - - . . . - . . .. .. . . - .... - - .. -.. -. .. - . - - .. -- ... -
SENSITIVE TO THE AMOUNT OF INACTIVE BROMIDE PR~SENT (fiG, 6), 
" -- . . - . . . - .. - - . - - . ·- - . -- - . - .. -· - . . . ... . -. - - ' ·. 
AGAIN NO RADIOBROMINATED PRODUCTS WERE DETECTED FROM URIDINE AND 
HISTIDINE IN THE CHLOROPEROXIDASE SYSTEM, 
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FIG. 6 
~ - . . . . : . . . - . . . . . 
BRO~INATION YIELDS FOLLO~ING ENZYME CATALYSED REACTION 
~·1 I TH 0 U?-ACfL; X TYROSINE; m cYTosINE. 
OPT I f·1Ui·1 YIELDS 
--
J :-lE OPT Ii·1Ul"1 YIELDS \•!ERE ALL ACHIEVED RAPIDLY AS SHm•/N IN ll\BLE 2, 
. . . .. . .. - ...... - .. .. -- - . -. ·- . - - - -"'.- .. . 
SitiCE THE CHROMATOGRAPHIC SEPARATION COULD B~ ACHIEVED WITHIN -
. . . . .. - ..... --. -· .. . . . . . -- ... -· ... -- ... 
10 MINUTES OF THE TERMINATION OF THE REACTIONSJ THE RADIOLABELLED 
PRODUCTS COULD BE OBTAINED IN AQUEOUS SOLUTIONJ FREE OF UNREACTED 
- .. . .. . .... - .. - ... -· - - ·--. -.. . ........ . 
HALIDE AND PARENT COMPOUNDJ. WITHIN 15 MINUTES OF ISOTOP~ 
. -- - - . . . .. .. .. . - - - .... --. -........ -
PRODUCTION USING THE CHLORAMINE-T REACTJON OR WIT~IN 30 MINUTES 
. 
. .. . . . . .. .. -
USING THE ENZYMATIC HALOGENATION, 
TABLE 2 
(HLORAMINE-T METHOD ENZYMATIC- r·1ETH01J -
- . 
- -- ... - . ~ . - . . . - . --- . -- . PRODUCT 0PTH,1UM YIEL.:O T I f'1E -
- OPT I r1Ut1 YIELD TIME" 
' I 
% /rHN rrr fr1IN lo 
1 ?~ 
-'I 86 <5 85 15 -TYROSINE 
125 T -J.-URACIL 95 ·<5 83 15 
-
1 25 I-CYTOSINE 85 <5 77 20 
... 2- - -
75 <5 I ::>1-URIDINE 92 20 
... z-
86 <5 I '1-HISIDii'IE 90 5 
BONER-TYROSINE 65 <5 83 r :> 
... 80'1 83 <5 89 5 l'•BR-URAC I L 
80··· 76 <5 68 10 I 'BR-CYTOSINE 

